data_2frw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2frw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.672 0.273 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.53 -165.9 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.555 2.17 . . . . 0.0 111.983 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -111.1 164.21 13.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.394 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -112.27 116.56 30.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 6' ' ' LYS . 24.3 t -83.31 142.61 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG11 ' A' ' 5' ' ' VAL . 16.7 mttt -108.95 -68.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 156.97 17.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.484 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -113.96 138.77 49.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.331 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.44 130.05 34.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.567 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.01 108.32 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.254 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 179.67 114.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.07 117.08 27.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.272 0.558 . . . . 0.0 111.131 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.27 158.46 37.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.228 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.598 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -54.1 106.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.0 t0 95.64 9.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.934 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.31 137.52 52.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -129.91 150.89 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.79 135.12 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.98 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 2.7 mt -95.36 150.75 19.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.004 0.43 . . . . 0.0 111.676 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 2.8 t -88.93 164.58 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.92 -35.43 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.027 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.31 67.92 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.605 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.13 -170.22 2.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.723 0.297 . . . . 0.0 110.713 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -120.53 140.75 51.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.147 0.499 . . . . 0.0 111.455 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 40' ' ' TYR . 25.4 t -136.18 158.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 30.3 p -97.13 95.5 7.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.569 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 10.1 p -104.87 101.99 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.007 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.87 101.33 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.226 0.536 . . . . 0.0 111.635 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 30' ' ' LYS . 29.1 tp10 -140.78 161.48 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.303 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 4.0 mttm -133.48 95.23 3.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.152 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.7 t -108.02 157.99 17.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.19 -6.6 59.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.804 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.99 173.19 6.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.99 76.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.997 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -80.06 127.9 32.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.4 . . . . 0.0 110.978 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 m0 -109.85 149.6 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.375 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -92.68 151.06 20.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.46 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -145.62 157.56 27.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.595 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.537 ' HA ' HG13 ' A' ' 44' ' ' ILE . 13.9 m -121.14 152.47 38.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.477 ' HA ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.3 137.04 40.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.86 86.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.49 -15.58 5.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.006 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.456 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -169.03 157.78 8.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.39 . . . . 0.0 110.375 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -133.85 158.24 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.172 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 169.16 -112.2 0.46 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 4.4 t90 -98.78 145.43 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.342 . . . . 0.0 111.105 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -64.54 128.91 93.93 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.479 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . 68.2 Cg_endo -89.16 12.99 2.55 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.902 2.401 . . . . 0.0 113.115 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.469 ' HB2' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -45.02 -16.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 2.8 m120 -41.53 -33.38 0.44 Allowed 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.106 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 65.6 m-85 -158.62 64.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.111 0.481 . . . . 0.0 109.817 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -139.34 163.52 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.147 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 42.9 tp -101.99 117.62 35.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.303 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.93 136.61 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.216 0.532 . . . . 0.0 112.287 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.06 115.87 19.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.066 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -83.87 78.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.233 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.4 t0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.865 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -85.99 -166.23 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.737 2.291 . . . . 0.0 112.54 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -129.4 156.76 43.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -107.77 116.03 31.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.383 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.09 149.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.459 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -106.18 -42.2 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 156.88 36.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -109.05 143.33 38.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -128.48 120.27 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.222 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 26.8 m -88.63 108.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 10' ' ' VAL . . . 161.68 110.42 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.061 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -123.08 113.9 19.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.408 0.623 . . . . 0.0 110.105 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -159.46 155.07 25.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.541 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 1.0 OUTLIER -63.12 105.43 0.7 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.488 178.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 13.7 t0 134.6 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.098 0.559 . . . . 0.0 111.585 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -97.52 150.3 21.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.444 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 46' ' ' TRP . 2.0 pp -111.62 120.84 43.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.314 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -85.7 147.18 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 10.8 mt -126.4 151.3 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.961 0.41 . . . . 0.0 111.641 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 2.4 t -96.0 162.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -81.0 -33.06 33.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.487 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.44 63.76 0.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.819 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -140.32 -178.23 5.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.666 0.27 . . . . 0.0 110.553 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -120.27 126.59 50.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.347 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 3' ' ' ALA . 45.5 t -111.53 162.01 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.102 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.571 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 0.6 OUTLIER -105.71 95.89 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.487 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 52' ' ' VAL . 13.2 p -104.92 113.45 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.89 100.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 112.471 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 40.6 tp10 -140.95 161.56 37.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.189 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.61 94.95 2.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.665 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.37 157.45 18.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.374 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.4 t -93.27 -46.68 7.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.331 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.4 97.59 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.453 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 159.33 -147.04 13.84 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.134 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -79.75 134.03 36.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.395 -0.903 . . . . 0.0 112.844 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -96.42 131.14 43.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.18 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -99.49 151.09 21.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.135 0.493 . . . . 0.0 111.613 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.73 165.28 26.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.718 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.571 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -116.86 156.82 26.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.69 0.281 . . . . 0.0 110.433 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 41' ' ' ASN . 7.7 t80 -149.16 144.99 26.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 24' ' ' ARG . 1.4 p30 -59.75 86.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.58 -34.46 1.8 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.93 168.55 8.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.841 0.353 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -110.71 152.68 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -166.74 -124.28 0.7 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.248 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 35' ' ' TRP . 1.6 t-105 -99.2 145.5 27.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 110.678 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 3.6 p90 -58.51 112.21 4.64 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.155 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' O ' ' CG1' ' A' ' 52' ' ' VAL . 91.9 Cg_endo -88.16 16.58 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.736 2.29 . . . . 0.0 112.598 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -56.47 -6.8 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.477 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 1.7 m120 -42.45 -30.88 0.37 Allowed 'General case' 0 C--N 1.342 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 66.6 m-85 -156.81 64.29 0.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.782 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -139.48 163.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.659 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -104.5 117.52 34.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.24 137.01 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.38 116.05 26.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.308 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.6 73.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.945 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 1' ' ' ILE . 20.6 mt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.678 0.275 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.485 ' HG2' ' HD2' ' A' ' 24' ' ' ARG . 97.8 Cg_endo -84.98 -164.66 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.72 2.28 . . . . 0.0 112.766 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -121.89 152.75 39.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -107.88 120.6 42.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.277 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.56 151.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.658 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 111.692 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.15 151.22 45.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' HB1' ' HG3' ' A' ' 21' ' ' LYS . . . -91.16 139.62 30.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.895 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -135.14 148.18 49.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 m -87.86 128.26 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.73 -169.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 73.4 mt-10 -81.89 176.76 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.713 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.8 -154.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.668 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 5.6 mm-40 -50.46 105.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 122.124 0.964 . . . . 0.0 110.682 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 21.2 t0 154.76 -54.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.229 -1.805 . . . . 0.0 107.533 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -128.53 150.43 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.943 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -121.53 150.65 41.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 p -70.69 150.13 46.27 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.499 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.69 150.72 20.17 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.207 0.527 . . . . 0.0 111.389 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' ALA . 3.3 t -69.15 161.08 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.142 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HG3' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -95.7 -39.21 10.0 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.162 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 62.75 0.3 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.753 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.19 176.0 10.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.731 0.3 . . . . 0.0 110.703 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' HD2' ' HG2' ' A' ' 2' ' ' PRO . 4.4 mmt85 -98.13 148.31 23.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.507 . . . . 0.0 111.54 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.73 166.45 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.439 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 7.0 p -80.39 139.46 36.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.12 128.05 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.517 0.675 . . . . 0.0 111.362 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.6 mmm -64.35 -176.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.997 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.421 ' HG2' ' CB ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -105.53 159.91 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.671 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -86.08 96.54 9.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -106.74 157.87 17.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.356 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 t -85.79 -27.67 25.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.62 164.65 12.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -19.83 44.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.654 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -80.02 91.84 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -90.03 128.66 36.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.421 ' CB ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.09 149.84 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.93 176.74 43.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.439 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -124.88 156.5 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.264 0.554 . . . . 0.0 111.493 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.25 145.57 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.91 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.35 86.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.471 . . . . 0.0 110.613 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.74 -39.25 0.74 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.84 177.45 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.897 0.38 . . . . 0.0 111.223 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.4 mp -124.59 156.94 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.829 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 162.76 -153.86 24.6 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.078 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -99.37 130.21 45.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.761 0.315 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.443 ' CE1' ' CD2' ' A' ' 17' ' ' LEU . 84.2 m-85 -124.53 132.33 24.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 47' ' ' PHE . 9.3 Cg_exo -71.17 105.81 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.548 2.165 . . . . 0.0 112.909 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.438 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 t -60.23 -7.87 2.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.2 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.45 -28.42 0.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.475 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -147.76 63.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.414 178.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.2 m -139.36 152.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.145 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 8.6 tp -115.41 116.79 28.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.35 136.92 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.81 117.22 30.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.005 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.54 84.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.242 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 t0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.974 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.62 0.248 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.59 -176.0 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.72 2.28 . . . . 0.0 112.047 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -111.31 153.51 25.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.428 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 m-30 -108.1 116.37 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.4 142.01 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.819 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -92.23 -96.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.103 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.15 148.69 24.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.174 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -86.45 141.01 29.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.433 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 27.6 t80 -135.44 139.45 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.624 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 m -88.65 113.15 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.256 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.327 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.5 117.87 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 111.338 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.697 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.13 173.49 16.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.382 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.697 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -53.5 107.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.473 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER 85.16 15.76 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -127.23 144.0 51.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -128.89 151.35 49.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.352 0.596 . . . . 0.0 111.877 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 p -88.3 148.22 24.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 9' ' ' TYR . 1.8 mt -94.19 150.68 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.367 0.604 . . . . 0.0 111.563 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -97.26 165.29 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.571 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -103.46 100.78 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.318 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.23 15.15 78.82 Favored Glycine 0 C--N 1.319 -0.382 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.632 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -86.54 176.43 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.048 0.424 . . . . 0.0 110.827 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mmt-85 -120.82 148.61 43.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 111.658 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.92 165.27 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.052 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 2.6 p -81.68 139.57 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.13 101.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 0.0 110.613 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.03 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.588 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.7 pt-20 -95.05 134.56 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.733 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -66.21 96.98 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.957 0.408 . . . . 0.0 110.489 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.8 149.24 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.721 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -93.34 -29.05 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.127 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.67 170.3 9.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.17 -22.2 9.55 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.987 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CD1' ' O ' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -79.75 133.19 36.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.585 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -134.36 125.35 27.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.037 0.446 . . . . 0.0 111.621 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -106.56 150.38 26.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.796 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.14 -169.96 33.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.945 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.492 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -129.36 156.75 43.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.31 0.576 . . . . 0.0 111.588 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' GLY . 77.2 t80 -139.38 145.55 39.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.918 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -59.56 86.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 110.62 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 148.04 -32.26 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.395 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -169.92 170.86 7.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 111.429 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.5 mp -119.04 158.34 20.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 160.01 -125.53 1.49 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.196 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.644 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -98.55 146.87 25.35 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 120.504 0.193 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -73.75 144.2 82.67 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.937 0.398 . . . . 0.0 111.807 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.513 ' O ' HG11 ' A' ' 52' ' ' VAL . 86.1 Cg_endo -94.64 33.99 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.262 2.642 . . . . 0.0 112.145 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.489 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -34.45 -28.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 48' ' ' PRO . 3.2 m-20 -41.66 -28.96 0.16 Allowed 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -160.58 64.89 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 110.206 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.63 163.34 28.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.397 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 8.5 tp -128.65 117.28 20.93 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.917 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -106.08 134.98 48.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.39 . . . . 0.0 111.792 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' ' CE2' ' A' ' 4' ' ' PHE . 1.7 mt-10 -103.27 115.97 31.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.75 85.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.274 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.55 0.214 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.17 -175.66 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.878 2.385 . . . . 0.0 112.572 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -97.51 171.34 8.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.192 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 2.9 t80 -127.38 119.22 25.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.945 0.403 . . . . 0.0 111.537 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' CG2' ' A' ' 25' ' ' VAL . 37.2 t -73.9 135.98 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.849 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -83.3 -72.2 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.55 150.11 35.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.56 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.425 ' CB ' ' CG ' ' A' ' 21' ' ' LYS . . . -88.21 132.11 34.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.003 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.479 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 55.5 t80 -134.74 148.01 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.07 141.35 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.79 -167.89 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -81.47 176.98 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.822 -179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.69 -154.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.084 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 15.4 mm-40 -50.29 105.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 122.127 0.965 . . . . 0.0 110.659 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 4.0 t70 152.45 -55.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.282 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -128.62 149.96 50.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.805 177.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -129.59 150.74 50.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -66.16 149.89 49.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.956 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 9' ' ' TYR . 2.4 mt -93.3 150.8 20.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.214 0.53 . . . . 0.0 111.309 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 2.5 t -76.08 161.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.995 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' CG ' ' CB ' ' A' ' 8' ' ' ALA . 1.2 mttt -90.18 -42.43 11.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.166 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.25 62.52 0.28 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.898 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -136.06 -170.07 2.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.625 -0.288 . . . . 0.0 110.651 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -120.43 132.26 55.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.264 0.554 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG2' ' CG2' ' A' ' 5' ' ' VAL . 21.4 t -110.56 166.57 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.471 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 11.6 p -80.27 139.21 36.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.736 0.303 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.27 122.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.571 0.7 . . . . 0.0 111.436 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 75.7 mmm -54.12 -176.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.0 pt-20 -111.24 140.12 46.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -69.64 96.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.53 154.12 21.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.327 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.0 t -93.36 -29.61 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.0 167.86 12.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.932 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.24 -16.3 53.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.97 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.47 96.15 7.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -89.98 125.56 35.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.095 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.65 149.73 21.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.53 -173.19 35.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.471 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -135.11 144.27 47.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.156 0.503 . . . . 0.0 111.282 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -140.87 145.55 36.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.082 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.51 86.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.142 0.496 . . . . 0.0 110.371 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 156.15 -40.77 0.58 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.066 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -169.98 162.16 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.7 mp -110.98 156.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 153.98 -137.56 5.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 31.4 m-90 -99.26 145.42 27.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' A' ' 17' ' ' LEU . 1.2 t80 -141.59 119.92 7.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.423 ' HG2' HD22 ' A' ' 19' ' ' LEU . 84.9 Cg_exo -50.6 88.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.832 2.355 . . . . 0.0 113.136 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.482 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -60.23 -12.24 8.34 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.205 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.75 -23.89 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.189 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -145.57 63.87 1.26 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.438 0.637 . . . . 0.0 110.571 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.5 m -138.71 151.18 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.214 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -106.57 117.68 34.67 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.92 49.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.477 . . . . 0.0 111.872 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -120.34 117.32 27.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.371 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.73 82.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 0.0 111.196 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.865 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.624 0.25 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.52 -165.91 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.604 2.203 . . . . 0.0 112.143 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.34 159.04 28.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.45 117.48 32.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.595 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.24 148.71 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -106.0 -75.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.14 156.92 16.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.58 147.45 28.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.551 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' HB2' ' A' ' 19' ' ' LEU . 6.4 t80 -135.5 135.85 40.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 26.9 m -88.89 108.23 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.266 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 10' ' ' VAL . . . 162.14 88.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 116.59 20.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.137 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.17 149.46 22.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.354 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 pt-20 -54.16 106.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 36.2 t70 124.69 -31.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.932 0.77 . . . . 0.0 110.364 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.34 149.94 28.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' CD2' ' CE3' ' A' ' 46' ' ' TRP . 3.2 pp -107.56 131.94 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.703 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 p -106.7 146.96 30.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.535 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HB2' ' N ' ' A' ' 9' ' ' TYR . 3.0 mm? -95.38 149.68 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.309 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.85 164.68 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.215 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -52.12 15.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.31 27.35 0.12 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.779 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 171.38 8.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -101.31 148.71 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.516 HG12 ' CE1' ' A' ' 40' ' ' TYR . 25.9 t -124.94 165.26 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.511 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 1.4 p -81.24 139.01 35.73 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.84 118.48 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.369 0.604 . . . . 0.0 111.216 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.454 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -60.55 -175.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.17 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -95.51 161.88 13.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.138 -179.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -126.35 99.47 5.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.861 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.26 157.97 17.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -59.89 -26.39 65.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.932 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.84 169.15 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.931 0.396 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 36' ' ' TRP . . . -74.18 -7.63 77.54 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.255 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CD1' ' O ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -86.49 133.16 33.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.992 0.396 . . . . 0.0 110.925 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 10.6 m-90 -141.12 126.13 18.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.37 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.4 149.05 24.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.076 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -134.07 158.43 23.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.852 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -111.07 153.35 25.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.516 ' CE1' HG12 ' A' ' 25' ' ' VAL . 8.1 m-85 -122.8 145.03 48.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.94 86.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.21 -15.32 7.3 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.568 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -159.25 174.83 14.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.292 . . . . 0.0 111.003 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.468 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.6 mp -136.96 156.83 35.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . -176.05 -146.18 5.85 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.432 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 2.1 t90 -99.3 146.36 26.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.961 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -55.73 113.24 5.32 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' O ' ' CG1' ' A' ' 52' ' ' VAL . 74.0 Cg_endo -94.49 37.04 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.091 2.527 . . . . 0.0 111.637 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.442 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -53.55 -9.6 0.21 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 3.3 m-20 -42.35 -30.43 0.33 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 91.3 m-85 -157.81 64.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.209 0.528 . . . . 0.0 109.745 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -139.01 163.46 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.476 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 18.2 tp -114.46 116.92 29.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.705 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.54 137.03 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.912 0.387 . . . . 0.0 112.009 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.26 115.83 26.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -96.43 80.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.88 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 1' ' ' ILE . 22.8 mt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.557 0.218 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.95 -170.75 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -98.0 170.93 8.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 53' ' ' LEU . 76.2 t80 -131.35 130.05 42.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.912 0.387 . . . . 0.0 111.729 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.1 t -85.12 135.74 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -86.79 -47.85 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.504 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.01 150.63 44.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.33 139.88 33.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . 6.6 t80 -135.67 125.09 24.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -88.79 108.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -178.57 104.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.3 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.49 117.58 22.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.289 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.718 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.3 175.24 14.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.392 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.718 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 19.3 pt-20 -53.62 108.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.384 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER 87.13 10.96 0.14 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HB3' ' CD ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.25 137.75 52.94 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.998 0.428 . . . . 0.0 110.721 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -129.73 143.42 50.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -76.86 147.33 37.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 3.8 mm? -95.24 150.5 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.127 0.489 . . . . 0.0 111.61 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' CG1' ' HE2' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -91.73 152.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HE2' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.22 -42.4 95.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.87 24.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.267 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.8 t -78.12 -171.63 2.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.101 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -118.85 148.65 42.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.058 0.456 . . . . 0.0 111.235 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 42.6 t -121.44 165.52 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.586 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 1.6 p -80.93 139.95 35.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 8.7 p -53.68 90.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 110.55 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.6 mpp? -57.8 -175.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.688 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.637 ' HB2' ' CD1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -95.93 161.19 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.011 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -135.29 96.69 3.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.947 0.403 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 36' ' ' TRP . 25.0 t -107.14 157.68 17.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.178 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -56.57 -43.96 80.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.8 167.87 20.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.45 -21.02 63.01 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.966 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -82.12 104.59 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.595 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.637 ' CD1' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -160.98 133.94 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 3.9 mtt180 -111.34 130.04 55.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 28' ' ' MET . . . -102.73 -160.61 25.79 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.555 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -134.63 152.74 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.455 0.645 . . . . 0.0 111.947 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.459 ' CE1' ' CD2' ' A' ' 17' ' ' LEU . 14.3 m-85 -132.0 144.84 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.813 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -60.9 86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.69 -20.36 4.36 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.711 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 1.8 pt20 -169.68 165.86 9.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.6 mp -117.54 159.41 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.074 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.448 ' HA2' ' NE ' ' A' ' 37' ' ' ARG . . . -175.47 -151.67 8.81 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.385 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 69.0 t90 -97.36 130.08 44.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.2 114.29 10.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.698 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' O ' HG13 ' A' ' 52' ' ' VAL . 81.6 Cg_endo -90.16 49.1 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.999 2.466 . . . . 0.0 111.711 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.9 m120 -42.37 -28.31 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.727 0.299 . . . . 0.0 111.418 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 61.4 m-85 -156.75 64.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.161 0.505 . . . . 0.0 109.944 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -138.91 163.32 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.648 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -126.53 116.78 21.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.45 127.06 53.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.871 0.367 . . . . 0.0 111.712 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.64 116.01 30.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.17 80.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.843 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.542 0.211 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.35 -167.43 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.715 2.277 . . . . 0.0 112.287 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -120.42 157.79 28.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 24' ' ' ARG . 6.3 m-85 -109.81 116.29 31.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 38.6 t -84.46 152.16 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.692 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 14.2 mtpt -111.53 -48.77 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 157.07 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.63 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.23 143.96 29.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.469 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 9.0 t80 -135.72 135.88 40.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 m -88.66 108.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.306 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.82 107.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.39 117.15 21.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 111.151 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.35 159.74 39.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.151 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.64 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 9.9 pt-20 -54.06 106.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.9 t0 97.47 0.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.961 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.35 129.46 47.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 46' ' ' TRP . 1.7 pt? -127.51 142.7 51.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -72.21 147.16 46.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.944 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 9' ' ' TYR . 5.0 mt -95.29 151.02 19.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.0 111.688 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -93.72 165.2 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.188 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.7 105.15 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.775 0.797 . . . . 0.0 111.295 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.57 18.58 73.9 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.375 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -97.91 -178.45 4.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -120.37 148.4 43.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.15 0.5 . . . . 0.0 111.25 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 3' ' ' ALA . 4.0 t -120.83 166.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.832 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 5.5 p -80.27 139.49 36.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -54.14 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.802 0.81 . . . . 0.0 111.651 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.469 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -51.93 -175.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.851 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.94 152.39 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.271 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.79 96.5 10.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.694 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 36' ' ' TRP . 13.0 t -99.42 143.16 29.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.827 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 -44.79 8.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.527 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -146.58 106.16 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.686 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.45 -134.55 5.22 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.841 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -104.53 133.95 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.817 0.341 . . . . 0.0 110.609 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.613 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -88.61 125.25 34.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 111.204 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -93.66 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.69 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -168.83 167.63 40.54 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.071 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.608 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.8 m -125.33 156.38 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 111.448 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -149.07 144.94 27.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.227 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.06 86.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.81 -27.43 1.46 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.395 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -169.74 167.52 9.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 111.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.1 mp -136.14 156.74 37.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.939 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 147.38 -100.39 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -99.21 146.29 26.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.48 148.67 74.03 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' O ' HG13 ' A' ' 52' ' ' VAL . 89.7 Cg_endo -93.12 32.21 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.062 2.508 . . . . 0.0 111.888 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.517 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -39.33 -21.63 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 1.7 m120 -41.31 -31.07 0.2 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 63.8 m-85 -160.69 64.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.864 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.77 163.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.223 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -124.2 117.84 25.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.734 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.4 129.87 53.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 0.0 111.768 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.53 138.17 32.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.748 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.88 75.81 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.267 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.878 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.537 0.208 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 92.8 Cg_endo -86.05 -167.13 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.602 2.201 . . . . 0.0 112.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -112.7 155.39 24.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 m-85 -109.2 116.38 31.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.673 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 158.62 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.687 0.28 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -114.54 -69.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.806 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.2 157.05 25.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.75 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.98 138.87 33.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.201 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.405 ' CB ' ' HB2' ' A' ' 19' ' ' LEU . 3.1 t80 -136.0 131.68 35.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.72 108.54 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.896 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 95.49 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.16 117.02 28.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.282 0.563 . . . . 0.0 110.921 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.577 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.17 156.65 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.173 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 6.8 pt-20 -54.04 106.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.7 t70 105.15 -17.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.922 0.764 . . . . 0.0 110.963 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -114.14 141.33 47.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.74 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -129.44 149.36 51.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.03 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 p -77.68 148.11 35.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 48' ' ' PRO . 3.5 mm? -94.42 148.96 21.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.04 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 1.9 t -95.81 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.323 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -36.12 81.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.189 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.02 32.09 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.265 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -79.09 -176.93 5.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.322 . . . . 0.0 110.894 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' NE ' ' CZ ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -120.45 148.73 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG11 ' CE2' ' A' ' 40' ' ' TYR . 40.6 t -119.89 165.85 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.687 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.619 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 1.6 p -80.41 140.79 35.84 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.68 97.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 122.06 0.933 . . . . 0.0 110.312 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -48.72 -176.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.768 -1.56 . . . . 0.0 112.744 -178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 2.6 pt-20 -96.0 161.96 13.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.754 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.19 144.28 36.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' HB2' ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -104.53 145.72 29.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.787 0.327 . . . . 0.0 110.781 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -93.47 -45.42 7.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -147.42 97.38 2.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.852 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.34 -41.68 0.13 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.302 0.881 . . . . 0.0 115.302 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CG ' ' O ' ' A' ' 35' ' ' TRP . 4.4 p-90 -79.31 113.13 17.2 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.983 0.892 . . . . 0.0 112.08 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -116.97 126.18 52.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.661 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 28' ' ' MET . 0.0 OUTLIER -104.74 150.03 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -149.39 171.82 29.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.107 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.619 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.6 m -131.77 156.92 45.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.394 0.616 . . . . 0.0 112.276 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CE2' HG11 ' A' ' 25' ' ' VAL . 1.2 m-85 -136.68 144.84 44.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -61.46 86.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.889 0.376 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.18 -13.77 5.97 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.138 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -168.88 152.4 5.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.072 0.436 . . . . 0.0 111.619 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -125.19 158.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 177.01 -144.47 6.81 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.618 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.74 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -98.76 138.1 36.4 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 110.773 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' CG ' ' HB3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -54.29 138.5 58.0 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ASN . 60.9 Cg_endo -99.86 28.96 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.976 3.118 . . . . 0.0 111.821 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -30.9 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 2.5 m120 -41.4 -32.43 0.32 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 69.0 m-85 -158.31 64.62 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 0.0 110.018 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -139.05 163.54 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 10.8 tp -129.23 117.19 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.958 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.1 131.47 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.715 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 2' ' ' PRO . 1.4 mt-10 -102.25 121.13 41.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.373 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.62 83.7 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.954 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.519 0.199 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.35 -166.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.682 2.255 . . . . 0.0 112.264 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.29 163.87 18.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.122 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -113.68 116.13 28.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.716 0.293 . . . . 0.0 111.086 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -87.68 145.38 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.7 -81.46 0.54 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.858 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.74 154.68 19.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.864 0.364 . . . . 0.0 111.427 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -115.11 145.55 42.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.862 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.404 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 5.3 t80 -135.6 139.45 43.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.494 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 m -88.75 108.48 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 169.26 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.244 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -127.74 116.73 20.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 110.511 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.05 153.44 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.862 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.51 106.32 0.28 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 11.8 t70 118.45 -28.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.481 0.712 . . . . 0.0 110.624 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 13' ' ' ARG . 12.8 pt-20 -106.04 150.04 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.207 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -127.01 121.03 30.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 11.3 p -80.41 147.07 31.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.769 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -95.56 151.13 19.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 0.0 111.479 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.52 164.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.2 -39.01 41.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.422 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.79 33.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.81 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.59 165.87 10.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.804 0.335 . . . . 0.0 110.804 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.12 148.61 23.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.21 164.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.254 0.549 . . . . 0.0 112.072 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 28' ' ' MET . 3.4 p -81.68 140.73 34.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.45 91.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 122.094 0.95 . . . . 0.0 110.577 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.531 ' CB ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -47.3 -175.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.659 -1.61 . . . . 0.0 113.458 -178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 11.5 pt-20 -95.75 161.3 14.08 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.088 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -109.05 96.15 6.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.406 ' SG ' ' CD1' ' A' ' 36' ' ' TRP . 13.2 p -97.41 158.13 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.128 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -90.44 -6.33 55.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.404 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -104.26 175.45 5.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.011 0.434 . . . . 0.0 111.044 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.0 74.28 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 35' ' ' TRP . 42.6 p-90 -79.99 98.94 7.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.364 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -89.96 125.07 35.24 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -96.25 150.19 20.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.88 -176.46 37.25 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.94 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.491 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -134.94 142.5 46.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.845 0.322 . . . . 0.0 111.06 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -137.37 144.4 42.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.55 90.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.45 -27.46 2.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.093 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.477 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.1 pt20 -169.72 154.51 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.6 mp -120.83 158.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.463 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 155.13 -128.3 2.27 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 25.5 m-90 -99.02 140.44 33.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.669 ' CE1' ' HB3' ' A' ' 36' ' ' TRP . 49.5 p90 -91.77 141.9 26.08 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' O ' HG11 ' A' ' 52' ' ' VAL . 41.6 Cg_endo -92.0 58.83 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.512 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.81 -19.57 0.68 Allowed 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -42.86 -27.88 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.663 0.268 . . . . 0.0 111.662 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -154.42 64.98 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.09 163.36 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -113.43 116.97 30.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.39 136.17 46.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.12 116.0 25.96 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.22 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.91 74.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 111.324 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.836 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.672 0.273 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.53 -165.9 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.555 2.17 . . . . 0.0 111.983 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -111.1 164.21 13.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.394 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -112.27 116.56 30.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 6' ' ' LYS . 24.3 t -83.31 142.61 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG11 ' A' ' 5' ' ' VAL . 16.7 mttt -108.95 -68.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 156.97 17.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.484 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -113.96 138.77 49.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.331 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.44 130.05 34.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.567 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.01 108.32 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.254 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 179.67 114.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.07 117.08 27.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.272 0.558 . . . . 0.0 111.131 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.27 158.46 37.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.228 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.598 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -54.1 106.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.0 t0 95.64 9.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.934 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.31 137.52 52.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -129.91 150.89 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.79 135.12 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.98 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 2.7 mt -95.36 150.75 19.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.004 0.43 . . . . 0.0 111.676 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 2.8 t -88.93 164.58 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.92 -35.43 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.027 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.31 67.92 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.605 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.13 -170.22 2.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.723 0.297 . . . . 0.0 110.713 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -120.53 140.75 51.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.147 0.499 . . . . 0.0 111.455 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 40' ' ' TYR . 25.4 t -136.18 158.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 30.3 p -97.13 95.5 7.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.569 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 10.1 p -104.87 101.99 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.007 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.87 101.33 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.226 0.536 . . . . 0.0 111.635 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 30' ' ' LYS . 29.1 tp10 -140.78 161.48 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.303 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 4.0 mttm -133.48 95.23 3.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.152 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.7 t -108.02 157.99 17.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.19 -6.6 59.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.804 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.99 173.19 6.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.99 76.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.997 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -80.06 127.9 32.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.4 . . . . 0.0 110.978 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 m0 -109.85 149.6 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.375 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -92.68 151.06 20.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.46 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -145.62 157.56 27.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.595 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.537 ' HA ' HG13 ' A' ' 44' ' ' ILE . 13.9 m -121.14 152.47 38.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.477 ' HA ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.3 137.04 40.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.86 86.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.49 -15.58 5.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.006 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.456 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -169.03 157.78 8.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.39 . . . . 0.0 110.375 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -133.85 158.24 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.172 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 169.16 -112.2 0.46 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 4.4 t90 -98.78 145.43 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.342 . . . . 0.0 111.105 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -64.54 128.91 93.93 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.479 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . 68.2 Cg_endo -89.16 12.99 2.55 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.902 2.401 . . . . 0.0 113.115 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.469 ' HB2' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -45.02 -16.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 2.8 m120 -41.53 -33.38 0.44 Allowed 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.106 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 65.6 m-85 -158.62 64.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.111 0.481 . . . . 0.0 109.817 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -139.34 163.52 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.147 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 42.9 tp -101.99 117.62 35.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.303 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.93 136.61 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.216 0.532 . . . . 0.0 112.287 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.06 115.87 19.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.066 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -83.87 78.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.233 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.4 t0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.865 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -85.99 -166.23 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.737 2.291 . . . . 0.0 112.54 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -129.4 156.76 43.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -107.77 116.03 31.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.383 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.09 149.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.459 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -106.18 -42.2 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 156.88 36.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -109.05 143.33 38.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -128.48 120.27 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.222 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 26.8 m -88.63 108.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 10' ' ' VAL . . . 161.68 110.42 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.061 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -123.08 113.9 19.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.408 0.623 . . . . 0.0 110.105 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -159.46 155.07 25.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.541 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 1.0 OUTLIER -63.12 105.43 0.7 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.488 178.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 13.7 t0 134.6 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.098 0.559 . . . . 0.0 111.585 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -97.52 150.3 21.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.444 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 46' ' ' TRP . 2.0 pp -111.62 120.84 43.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.314 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -85.7 147.18 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 10.8 mt -126.4 151.3 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.961 0.41 . . . . 0.0 111.641 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 2.4 t -96.0 162.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -81.0 -33.06 33.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.487 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.44 63.76 0.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.819 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -140.32 -178.23 5.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.666 0.27 . . . . 0.0 110.553 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -120.27 126.59 50.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.347 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 3' ' ' ALA . 45.5 t -111.53 162.01 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.102 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.571 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 0.6 OUTLIER -105.71 95.89 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.487 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 52' ' ' VAL . 13.2 p -104.92 113.45 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.89 100.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 112.471 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 40.6 tp10 -140.95 161.56 37.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.189 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.61 94.95 2.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.665 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.37 157.45 18.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.374 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.4 t -93.27 -46.68 7.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.331 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.4 97.59 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.453 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 159.33 -147.04 13.84 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.134 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -79.75 134.03 36.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.395 -0.903 . . . . 0.0 112.844 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -96.42 131.14 43.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.18 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -99.49 151.09 21.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.135 0.493 . . . . 0.0 111.613 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.73 165.28 26.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.718 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.571 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -116.86 156.82 26.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.69 0.281 . . . . 0.0 110.433 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 41' ' ' ASN . 7.7 t80 -149.16 144.99 26.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 24' ' ' ARG . 1.4 p30 -59.75 86.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.58 -34.46 1.8 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.93 168.55 8.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.841 0.353 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -110.71 152.68 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -166.74 -124.28 0.7 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.248 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 35' ' ' TRP . 1.6 t-105 -99.2 145.5 27.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 110.678 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 3.6 p90 -58.51 112.21 4.64 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.155 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' O ' ' CG1' ' A' ' 52' ' ' VAL . 91.9 Cg_endo -88.16 16.58 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.736 2.29 . . . . 0.0 112.598 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -56.47 -6.8 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.477 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 1.7 m120 -42.45 -30.88 0.37 Allowed 'General case' 0 C--N 1.342 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 66.6 m-85 -156.81 64.29 0.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.782 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -139.48 163.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.659 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -104.5 117.52 34.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.24 137.01 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.38 116.05 26.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.308 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.6 73.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.945 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 1' ' ' ILE . 20.6 mt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.678 0.275 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.485 ' HG2' ' HD2' ' A' ' 24' ' ' ARG . 97.8 Cg_endo -84.98 -164.66 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.72 2.28 . . . . 0.0 112.766 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -121.89 152.75 39.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -107.88 120.6 42.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.277 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.56 151.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.658 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 111.692 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.15 151.22 45.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' HB1' ' HG3' ' A' ' 21' ' ' LYS . . . -91.16 139.62 30.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.895 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -135.14 148.18 49.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 m -87.86 128.26 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.73 -169.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 73.4 mt-10 -81.89 176.76 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.713 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.8 -154.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.668 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 5.6 mm-40 -50.46 105.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 122.124 0.964 . . . . 0.0 110.682 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 21.2 t0 154.76 -54.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.229 -1.805 . . . . 0.0 107.533 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -128.53 150.43 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.943 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -121.53 150.65 41.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 p -70.69 150.13 46.27 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.499 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.69 150.72 20.17 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.207 0.527 . . . . 0.0 111.389 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' ALA . 3.3 t -69.15 161.08 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.142 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HG3' ' HB1' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -95.7 -39.21 10.0 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.162 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 62.75 0.3 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.753 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.19 176.0 10.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.731 0.3 . . . . 0.0 110.703 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' HD2' ' HG2' ' A' ' 2' ' ' PRO . 4.4 mmt85 -98.13 148.31 23.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.507 . . . . 0.0 111.54 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.73 166.45 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.439 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 7.0 p -80.39 139.46 36.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.12 128.05 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.517 0.675 . . . . 0.0 111.362 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.6 mmm -64.35 -176.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.997 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.421 ' HG2' ' CB ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -105.53 159.91 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.671 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -86.08 96.54 9.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -106.74 157.87 17.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.356 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 t -85.79 -27.67 25.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.62 164.65 12.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -19.83 44.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.654 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -80.02 91.84 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -90.03 128.66 36.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' CB ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.09 149.84 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.93 176.74 43.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.439 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -124.88 156.5 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.264 0.554 . . . . 0.0 111.493 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.25 145.57 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.91 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.35 86.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.471 . . . . 0.0 110.613 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.74 -39.25 0.74 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.84 177.45 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.897 0.38 . . . . 0.0 111.223 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.4 mp -124.59 156.94 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.829 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 162.76 -153.86 24.6 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.078 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -99.37 130.21 45.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.761 0.315 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.443 ' CE1' ' CD2' ' A' ' 17' ' ' LEU . 84.2 m-85 -124.53 132.33 24.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 47' ' ' PHE . 9.3 Cg_exo -71.17 105.81 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.548 2.165 . . . . 0.0 112.909 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.438 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 t -60.23 -7.87 2.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.2 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.45 -28.42 0.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.475 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -147.76 63.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.414 178.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.2 m -139.36 152.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.145 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 8.6 tp -115.41 116.79 28.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.35 136.92 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.81 117.22 30.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.005 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.54 84.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.242 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 t0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.974 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.62 0.248 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.59 -176.0 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.72 2.28 . . . . 0.0 112.047 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -111.31 153.51 25.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 m-30 -108.1 116.37 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.4 142.01 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.819 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -92.23 -96.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.103 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.15 148.69 24.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.174 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -86.45 141.01 29.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.433 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 27.6 t80 -135.44 139.45 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.624 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 m -88.65 113.15 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.256 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.327 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.5 117.87 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 111.338 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.697 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.13 173.49 16.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.382 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.697 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -53.5 107.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.473 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER 85.16 15.76 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -127.23 144.0 51.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -128.89 151.35 49.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.352 0.596 . . . . 0.0 111.877 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 p -88.3 148.22 24.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 9' ' ' TYR . 1.8 mt -94.19 150.68 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.367 0.604 . . . . 0.0 111.563 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -97.26 165.29 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.571 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -103.46 100.78 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.318 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.23 15.15 78.82 Favored Glycine 0 C--N 1.319 -0.382 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.632 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -86.54 176.43 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.048 0.424 . . . . 0.0 110.827 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mmt-85 -120.82 148.61 43.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 111.658 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.92 165.27 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.052 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 2.6 p -81.68 139.57 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.13 101.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 0.0 110.613 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.03 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.588 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.7 pt-20 -95.05 134.56 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.733 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -66.21 96.98 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.957 0.408 . . . . 0.0 110.489 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.8 149.24 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.721 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -93.34 -29.05 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.127 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.67 170.3 9.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.17 -22.2 9.55 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.987 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CD1' ' O ' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -79.75 133.19 36.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.585 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -134.36 125.35 27.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.037 0.446 . . . . 0.0 111.621 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -106.56 150.38 26.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.796 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.14 -169.96 33.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.945 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.492 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -129.36 156.75 43.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.31 0.576 . . . . 0.0 111.588 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' GLY . 77.2 t80 -139.38 145.55 39.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.918 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -59.56 86.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 110.62 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 148.04 -32.26 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.395 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -169.92 170.86 7.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 111.429 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.5 mp -119.04 158.34 20.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 160.01 -125.53 1.49 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.196 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.644 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -98.55 146.87 25.35 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 120.504 0.193 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -73.75 144.2 82.67 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.937 0.398 . . . . 0.0 111.807 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.513 ' O ' HG11 ' A' ' 52' ' ' VAL . 86.1 Cg_endo -94.64 33.99 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.262 2.642 . . . . 0.0 112.145 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.489 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -34.45 -28.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 48' ' ' PRO . 3.2 m-20 -41.66 -28.96 0.16 Allowed 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -160.58 64.89 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 110.206 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.63 163.34 28.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.397 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 8.5 tp -128.65 117.28 20.93 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.917 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -106.08 134.98 48.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.39 . . . . 0.0 111.792 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' ' CE2' ' A' ' 4' ' ' PHE . 1.7 mt-10 -103.27 115.97 31.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.75 85.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.274 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.55 0.214 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.17 -175.66 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.878 2.385 . . . . 0.0 112.572 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -97.51 171.34 8.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.192 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 2.9 t80 -127.38 119.22 25.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.945 0.403 . . . . 0.0 111.537 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' CG2' ' CG2' ' A' ' 25' ' ' VAL . 37.2 t -73.9 135.98 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.849 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -83.3 -72.2 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.55 150.11 35.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.56 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.425 ' CB ' ' CG ' ' A' ' 21' ' ' LYS . . . -88.21 132.11 34.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.003 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.479 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 55.5 t80 -134.74 148.01 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.07 141.35 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.79 -167.89 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -81.47 176.98 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.822 -179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.69 -154.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.084 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 15.4 mm-40 -50.29 105.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 122.127 0.965 . . . . 0.0 110.659 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 4.0 t70 152.45 -55.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.282 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -128.62 149.96 50.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.805 177.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -129.59 150.74 50.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -66.16 149.89 49.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.956 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 9' ' ' TYR . 2.4 mt -93.3 150.8 20.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.214 0.53 . . . . 0.0 111.309 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 2.5 t -76.08 161.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.995 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' CG ' ' CB ' ' A' ' 8' ' ' ALA . 1.2 mttt -90.18 -42.43 11.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.166 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.25 62.52 0.28 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.898 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -136.06 -170.07 2.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.625 -0.288 . . . . 0.0 110.651 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -120.43 132.26 55.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.264 0.554 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG2' ' CG2' ' A' ' 5' ' ' VAL . 21.4 t -110.56 166.57 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.471 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 11.6 p -80.27 139.21 36.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.736 0.303 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.27 122.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.571 0.7 . . . . 0.0 111.436 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 75.7 mmm -54.12 -176.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.0 pt-20 -111.24 140.12 46.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -69.64 96.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.53 154.12 21.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.327 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.0 t -93.36 -29.61 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.0 167.86 12.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.932 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.24 -16.3 53.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.97 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.47 96.15 7.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -89.98 125.56 35.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.095 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.65 149.73 21.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.53 -173.19 35.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.471 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -135.11 144.27 47.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.156 0.503 . . . . 0.0 111.282 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -140.87 145.55 36.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.082 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.51 86.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.142 0.496 . . . . 0.0 110.371 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 156.15 -40.77 0.58 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.066 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -169.98 162.16 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.7 mp -110.98 156.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 153.98 -137.56 5.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 31.4 m-90 -99.26 145.42 27.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' A' ' 17' ' ' LEU . 1.2 t80 -141.59 119.92 7.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' HG2' HD22 ' A' ' 19' ' ' LEU . 84.9 Cg_exo -50.6 88.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.832 2.355 . . . . 0.0 113.136 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.482 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -60.23 -12.24 8.34 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.205 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.75 -23.89 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.189 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -145.57 63.87 1.26 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.438 0.637 . . . . 0.0 110.571 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.5 m -138.71 151.18 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.214 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -106.57 117.68 34.67 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.92 49.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.477 . . . . 0.0 111.872 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -120.34 117.32 27.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.371 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.73 82.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 0.0 111.196 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.865 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.624 0.25 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.52 -165.91 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.604 2.203 . . . . 0.0 112.143 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.34 159.04 28.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.45 117.48 32.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.595 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.24 148.71 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -106.0 -75.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.14 156.92 16.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.58 147.45 28.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.551 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' HB2' ' A' ' 19' ' ' LEU . 6.4 t80 -135.5 135.85 40.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 26.9 m -88.89 108.23 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.266 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 10' ' ' VAL . . . 162.14 88.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 116.59 20.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.137 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.17 149.46 22.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.354 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 pt-20 -54.16 106.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 36.2 t70 124.69 -31.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.932 0.77 . . . . 0.0 110.364 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.34 149.94 28.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.614 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' CD2' ' CE3' ' A' ' 46' ' ' TRP . 3.2 pp -107.56 131.94 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.703 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.4 p -106.7 146.96 30.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.535 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HB2' ' N ' ' A' ' 9' ' ' TYR . 3.0 mm? -95.38 149.68 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.309 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.85 164.68 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.215 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -52.12 15.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.31 27.35 0.12 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.779 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 171.38 8.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -101.31 148.71 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.516 HG12 ' CE1' ' A' ' 40' ' ' TYR . 25.9 t -124.94 165.26 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.511 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 1.4 p -81.24 139.01 35.73 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.84 118.48 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.369 0.604 . . . . 0.0 111.216 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.454 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -60.55 -175.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.17 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -95.51 161.88 13.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.138 -179.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -126.35 99.47 5.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.861 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.26 157.97 17.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -59.89 -26.39 65.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.932 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.84 169.15 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.931 0.396 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 36' ' ' TRP . . . -74.18 -7.63 77.54 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.255 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CD1' ' O ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -86.49 133.16 33.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.992 0.396 . . . . 0.0 110.925 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 10.6 m-90 -141.12 126.13 18.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.37 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.4 149.05 24.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.076 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -134.07 158.43 23.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.852 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -111.07 153.35 25.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.516 ' CE1' HG12 ' A' ' 25' ' ' VAL . 8.1 m-85 -122.8 145.03 48.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.94 86.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.21 -15.32 7.3 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.568 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -159.25 174.83 14.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.292 . . . . 0.0 111.003 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.468 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.6 mp -136.96 156.83 35.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . -176.05 -146.18 5.85 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.432 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 2.1 t90 -99.3 146.36 26.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.961 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -55.73 113.24 5.32 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' O ' ' CG1' ' A' ' 52' ' ' VAL . 74.0 Cg_endo -94.49 37.04 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.091 2.527 . . . . 0.0 111.637 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.442 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -53.55 -9.6 0.21 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 3.3 m-20 -42.35 -30.43 0.33 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 91.3 m-85 -157.81 64.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.209 0.528 . . . . 0.0 109.745 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -139.01 163.46 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.476 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 18.2 tp -114.46 116.92 29.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.705 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.54 137.03 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.912 0.387 . . . . 0.0 112.009 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.26 115.83 26.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -96.43 80.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.88 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 1' ' ' ILE . 22.8 mt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.557 0.218 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.95 -170.75 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -98.0 170.93 8.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 53' ' ' LEU . 76.2 t80 -131.35 130.05 42.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.912 0.387 . . . . 0.0 111.729 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.1 t -85.12 135.74 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -86.79 -47.85 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.504 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.01 150.63 44.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.33 139.88 33.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . 6.6 t80 -135.67 125.09 24.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 m -88.79 108.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -178.57 104.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.3 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.49 117.58 22.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.289 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.718 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.3 175.24 14.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.392 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.718 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 19.3 pt-20 -53.62 108.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.384 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER 87.13 10.96 0.14 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HB3' ' CD ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.25 137.75 52.94 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.998 0.428 . . . . 0.0 110.721 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -129.73 143.42 50.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -76.86 147.33 37.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 3.8 mm? -95.24 150.5 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.127 0.489 . . . . 0.0 111.61 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' CG1' ' HE2' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -91.73 152.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HE2' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.22 -42.4 95.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.87 24.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.267 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.8 t -78.12 -171.63 2.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.101 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -118.85 148.65 42.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.058 0.456 . . . . 0.0 111.235 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 42.6 t -121.44 165.52 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.586 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 39' ' ' SER . 1.6 p -80.93 139.95 35.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 8.7 p -53.68 90.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 110.55 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.6 mpp? -57.8 -175.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.688 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.637 ' HB2' ' CD1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -95.93 161.19 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.011 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -135.29 96.69 3.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.947 0.403 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 36' ' ' TRP . 25.0 t -107.14 157.68 17.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.178 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -56.57 -43.96 80.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.8 167.87 20.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.45 -21.02 63.01 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.966 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -82.12 104.59 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.595 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.637 ' CD1' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -160.98 133.94 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 3.9 mtt180 -111.34 130.04 55.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 28' ' ' MET . . . -102.73 -160.61 25.79 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.555 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -134.63 152.74 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.455 0.645 . . . . 0.0 111.947 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.459 ' CE1' ' CD2' ' A' ' 17' ' ' LEU . 14.3 m-85 -132.0 144.84 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.813 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -60.9 86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.69 -20.36 4.36 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.711 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 1.8 pt20 -169.68 165.86 9.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.6 mp -117.54 159.41 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.074 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.448 ' HA2' ' NE ' ' A' ' 37' ' ' ARG . . . -175.47 -151.67 8.81 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.385 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 69.0 t90 -97.36 130.08 44.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.2 114.29 10.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.698 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' O ' HG13 ' A' ' 52' ' ' VAL . 81.6 Cg_endo -90.16 49.1 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.999 2.466 . . . . 0.0 111.711 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.9 m120 -42.37 -28.31 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.727 0.299 . . . . 0.0 111.418 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 61.4 m-85 -156.75 64.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.161 0.505 . . . . 0.0 109.944 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -138.91 163.32 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.648 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -126.53 116.78 21.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.45 127.06 53.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.871 0.367 . . . . 0.0 111.712 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.64 116.01 30.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.17 80.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.843 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.542 0.211 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.35 -167.43 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.715 2.277 . . . . 0.0 112.287 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -120.42 157.79 28.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 24' ' ' ARG . 6.3 m-85 -109.81 116.29 31.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 38.6 t -84.46 152.16 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.692 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 14.2 mtpt -111.53 -48.77 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 157.07 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.63 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.23 143.96 29.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.469 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 9.0 t80 -135.72 135.88 40.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 m -88.66 108.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.306 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.82 107.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.39 117.15 21.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 111.151 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.35 159.74 39.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.151 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.64 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 9.9 pt-20 -54.06 106.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.9 t0 97.47 0.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.961 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.35 129.46 47.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 46' ' ' TRP . 1.7 pt? -127.51 142.7 51.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -72.21 147.16 46.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.944 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 9' ' ' TYR . 5.0 mt -95.29 151.02 19.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.0 111.688 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -93.72 165.2 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.188 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.7 105.15 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.775 0.797 . . . . 0.0 111.295 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.57 18.58 73.9 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.375 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -97.91 -178.45 4.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -120.37 148.4 43.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.15 0.5 . . . . 0.0 111.25 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 3' ' ' ALA . 4.0 t -120.83 166.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.832 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 5.5 p -80.27 139.49 36.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -54.14 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.802 0.81 . . . . 0.0 111.651 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.469 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -51.93 -175.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.851 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.94 152.39 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.271 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.79 96.5 10.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.694 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 36' ' ' TRP . 13.0 t -99.42 143.16 29.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.827 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 -44.79 8.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.527 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -146.58 106.16 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.686 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.45 -134.55 5.22 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.841 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -104.53 133.95 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.817 0.341 . . . . 0.0 110.609 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.613 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -88.61 125.25 34.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 111.204 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -93.66 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.69 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -168.83 167.63 40.54 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.071 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.608 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.8 m -125.33 156.38 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 111.448 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -149.07 144.94 27.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.227 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.06 86.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.81 -27.43 1.46 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.395 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -169.74 167.52 9.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 111.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.1 mp -136.14 156.74 37.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.939 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 147.38 -100.39 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -99.21 146.29 26.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.48 148.67 74.03 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' O ' HG13 ' A' ' 52' ' ' VAL . 89.7 Cg_endo -93.12 32.21 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.062 2.508 . . . . 0.0 111.888 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.517 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -39.33 -21.63 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 1.7 m120 -41.31 -31.07 0.2 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 63.8 m-85 -160.69 64.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.864 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.77 163.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.223 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -124.2 117.84 25.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.734 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.4 129.87 53.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 0.0 111.768 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.53 138.17 32.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.748 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.88 75.81 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.267 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.878 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.537 0.208 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 92.8 Cg_endo -86.05 -167.13 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.602 2.201 . . . . 0.0 112.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 53' ' ' LEU . . . -112.7 155.39 24.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 m-85 -109.2 116.38 31.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.673 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.63 158.62 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.687 0.28 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -114.54 -69.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.806 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.2 157.05 25.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.75 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.98 138.87 33.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.201 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.405 ' CB ' ' HB2' ' A' ' 19' ' ' LEU . 3.1 t80 -136.0 131.68 35.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.72 108.54 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.896 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 95.49 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.16 117.02 28.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.282 0.563 . . . . 0.0 110.921 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.577 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.17 156.65 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.173 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 6.8 pt-20 -54.04 106.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.7 t70 105.15 -17.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.922 0.764 . . . . 0.0 110.963 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -114.14 141.33 47.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.74 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -129.44 149.36 51.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.03 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 p -77.68 148.11 35.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 48' ' ' PRO . 3.5 mm? -94.42 148.96 21.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.04 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 1.9 t -95.81 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.323 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -36.12 81.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.189 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.02 32.09 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.265 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -79.09 -176.93 5.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.322 . . . . 0.0 110.894 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' NE ' ' CZ ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -120.45 148.73 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG11 ' CE2' ' A' ' 40' ' ' TYR . 40.6 t -119.89 165.85 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.687 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.619 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 1.6 p -80.41 140.79 35.84 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.68 97.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 122.06 0.933 . . . . 0.0 110.312 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -48.72 -176.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.768 -1.56 . . . . 0.0 112.744 -178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 2.6 pt-20 -96.0 161.96 13.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.754 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.19 144.28 36.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' HB2' ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -104.53 145.72 29.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.787 0.327 . . . . 0.0 110.781 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -93.47 -45.42 7.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -147.42 97.38 2.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.852 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.34 -41.68 0.13 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.302 0.881 . . . . 0.0 115.302 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CG ' ' O ' ' A' ' 35' ' ' TRP . 4.4 p-90 -79.31 113.13 17.2 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.983 0.892 . . . . 0.0 112.08 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -116.97 126.18 52.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.661 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 28' ' ' MET . 0.0 OUTLIER -104.74 150.03 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -149.39 171.82 29.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.107 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.619 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.6 m -131.77 156.92 45.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.394 0.616 . . . . 0.0 112.276 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CE2' HG11 ' A' ' 25' ' ' VAL . 1.2 m-85 -136.68 144.84 44.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -61.46 86.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.889 0.376 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.18 -13.77 5.97 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.138 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -168.88 152.4 5.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.072 0.436 . . . . 0.0 111.619 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -125.19 158.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 177.01 -144.47 6.81 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.618 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.74 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -98.76 138.1 36.4 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 110.773 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' CG ' ' HB3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -54.29 138.5 58.0 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ASN . 60.9 Cg_endo -99.86 28.96 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.976 3.118 . . . . 0.0 111.821 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -30.9 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 2.5 m120 -41.4 -32.43 0.32 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 69.0 m-85 -158.31 64.62 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 0.0 110.018 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -139.05 163.54 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 10.8 tp -129.23 117.19 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.958 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.1 131.47 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.715 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 2' ' ' PRO . 1.4 mt-10 -102.25 121.13 41.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.373 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.62 83.7 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.954 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.519 0.199 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.35 -166.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.682 2.255 . . . . 0.0 112.264 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.29 163.87 18.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.122 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -113.68 116.13 28.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.716 0.293 . . . . 0.0 111.086 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -87.68 145.38 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.7 -81.46 0.54 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.858 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.74 154.68 19.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.864 0.364 . . . . 0.0 111.427 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -115.11 145.55 42.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.862 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.404 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 5.3 t80 -135.6 139.45 43.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.494 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 m -88.75 108.48 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 169.26 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.244 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -127.74 116.73 20.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 110.511 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.05 153.44 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.862 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.51 106.32 0.28 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 11.8 t70 118.45 -28.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.481 0.712 . . . . 0.0 110.624 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 13' ' ' ARG . 12.8 pt-20 -106.04 150.04 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.207 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -127.01 121.03 30.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 11.3 p -80.41 147.07 31.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.769 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -95.56 151.13 19.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 0.0 111.479 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.52 164.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.2 -39.01 41.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.422 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.79 33.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.81 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.59 165.87 10.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.804 0.335 . . . . 0.0 110.804 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.12 148.61 23.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.21 164.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.254 0.549 . . . . 0.0 112.072 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 28' ' ' MET . 3.4 p -81.68 140.73 34.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.45 91.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 122.094 0.95 . . . . 0.0 110.577 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.531 ' CB ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -47.3 -175.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.659 -1.61 . . . . 0.0 113.458 -178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 11.5 pt-20 -95.75 161.3 14.08 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.088 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -109.05 96.15 6.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.406 ' SG ' ' CD1' ' A' ' 36' ' ' TRP . 13.2 p -97.41 158.13 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.128 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -90.44 -6.33 55.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.404 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -104.26 175.45 5.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.011 0.434 . . . . 0.0 111.044 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.0 74.28 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 35' ' ' TRP . 42.6 p-90 -79.99 98.94 7.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.364 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -89.96 125.07 35.24 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -96.25 150.19 20.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.88 -176.46 37.25 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.94 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.491 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -134.94 142.5 46.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.845 0.322 . . . . 0.0 111.06 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -137.37 144.4 42.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.55 90.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.45 -27.46 2.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.093 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.477 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 1.1 pt20 -169.72 154.51 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.6 mp -120.83 158.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.463 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 155.13 -128.3 2.27 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 25.5 m-90 -99.02 140.44 33.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.669 ' CE1' ' HB3' ' A' ' 36' ' ' TRP . 49.5 p90 -91.77 141.9 26.08 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' O ' HG11 ' A' ' 52' ' ' VAL . 41.6 Cg_endo -92.0 58.83 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.512 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.81 -19.57 0.68 Allowed 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -42.86 -27.88 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.663 0.268 . . . . 0.0 111.662 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -154.42 64.98 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.09 163.36 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -113.43 116.97 30.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.39 136.17 46.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.12 116.0 25.96 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.22 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.91 74.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 111.324 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.836 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.672 0.273 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.53 -165.9 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.555 2.17 . . . . 0.0 111.983 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.733 ' HB2' HG12 ' A' ' 27' ' ' VAL . . . -111.1 164.21 13.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.394 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 28.7 t80 -112.27 116.56 30.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' HG23 ' A' ' 25' ' ' VAL . 24.3 t -83.31 142.61 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -108.95 -68.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 156.97 17.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.484 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.557 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -113.96 138.77 49.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.331 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.801 ' HB2' HD12 ' A' ' 19' ' ' LEU . 8.0 t80 -135.44 130.05 34.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.567 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 10' ' ' VAL . 5.7 m -101.01 108.32 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.254 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 16' ' ' GLU . . . 179.67 114.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.07 117.08 27.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.272 0.558 . . . . 0.0 111.131 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.599 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.27 158.46 37.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.228 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.599 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -54.1 106.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.0 t0 95.64 9.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.934 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.31 137.52 52.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -129.91 150.89 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.79 135.12 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.98 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 9' ' ' TYR . 2.7 mt -95.36 150.75 19.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.004 0.43 . . . . 0.0 111.676 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.794 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.8 t -88.93 164.58 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.92 -35.43 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.027 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.31 67.92 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.605 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.794 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.13 -170.22 2.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.723 0.297 . . . . 0.0 110.713 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -120.53 140.75 51.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.147 0.499 . . . . 0.0 111.455 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 40' ' ' TYR . 25.4 t -136.18 158.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 30.3 p -97.13 95.5 7.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.569 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 47' ' ' PHE . 10.1 p -104.87 101.99 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.007 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.87 101.33 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.226 0.536 . . . . 0.0 111.635 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 29.1 tp10 -140.78 161.48 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.303 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 4.0 mttm -133.48 95.23 3.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.152 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.7 t -108.02 157.99 17.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.19 -6.6 59.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.804 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.99 173.19 6.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.99 76.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.997 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -80.06 127.9 32.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.4 . . . . 0.0 110.978 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 m0 -109.85 149.6 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.375 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -92.68 151.06 20.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.46 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -145.62 157.56 27.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.595 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 44' ' ' ILE . 13.9 m -121.14 152.47 38.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.3 137.04 40.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 86.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.49 -15.58 5.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.006 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.781 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -169.03 157.78 8.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.39 . . . . 0.0 110.375 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -133.85 158.24 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.172 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 169.16 -112.2 0.46 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.815 ' O ' HD22 ' A' ' 17' ' ' LEU . 4.4 t90 -98.78 145.43 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.342 . . . . 0.0 111.105 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.77 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -64.54 128.91 93.93 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.479 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.83 ' HA ' HD21 ' A' ' 17' ' ' LEU . 68.2 Cg_endo -89.16 12.99 2.55 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.902 2.401 . . . . 0.0 113.115 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.825 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -45.02 -16.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 2.8 m120 -41.53 -33.38 0.44 Allowed 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.106 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 65.6 m-85 -158.62 64.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.111 0.481 . . . . 0.0 109.817 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.34 163.52 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.147 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 42.9 tp -101.99 117.62 35.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.303 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.93 136.61 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.216 0.532 . . . . 0.0 112.287 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.06 115.87 19.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.066 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -83.87 78.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.233 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.4 t0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.865 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ILE . . . . . 0.608 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -85.99 -166.23 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.737 2.291 . . . . 0.0 112.54 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -129.4 156.76 43.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -107.77 116.03 31.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.383 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 45.8 t -82.09 149.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.459 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -106.18 -42.2 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 156.88 36.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -109.05 143.33 38.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -128.48 120.27 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.222 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.8 m -88.63 108.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 161.68 110.42 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.061 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -123.08 113.9 19.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.408 0.623 . . . . 0.0 110.105 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -159.46 155.07 25.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.541 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 1.0 OUTLIER -63.12 105.43 0.7 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.488 178.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 13.7 t0 134.6 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.098 0.559 . . . . 0.0 111.585 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -97.52 150.3 21.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.444 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 47' ' ' PHE . 2.0 pp -111.62 120.84 43.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.314 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.545 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.6 p -85.7 147.18 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 17' ' ' LEU . 10.8 mt -126.4 151.3 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.961 0.41 . . . . 0.0 111.641 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.4 t -96.0 162.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.648 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -81.0 -33.06 33.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.487 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.44 63.76 0.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.819 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.681 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -140.32 -178.23 5.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.666 0.27 . . . . 0.0 110.553 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -120.27 126.59 50.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.347 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.704 HG22 ' CE2' ' A' ' 40' ' ' TYR . 45.5 t -111.53 162.01 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.102 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 0.6 OUTLIER -105.71 95.89 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.487 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.2 p -104.92 113.45 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.89 100.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 112.471 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 40.6 tp10 -140.95 161.56 37.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.189 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.61 94.95 2.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.665 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.37 157.45 18.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.374 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.4 t -93.27 -46.68 7.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.331 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.4 97.59 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.453 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 159.33 -147.04 13.84 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.134 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -79.75 134.03 36.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.395 -0.903 . . . . 0.0 112.844 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -96.42 131.14 43.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.18 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -99.49 151.09 21.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.135 0.493 . . . . 0.0 111.613 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.73 165.28 26.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.718 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -116.86 156.82 26.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.69 0.281 . . . . 0.0 110.433 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CE2' HG22 ' A' ' 25' ' ' VAL . 7.7 t80 -149.16 144.99 26.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 1.7 p-10 -59.75 86.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.58 -34.46 1.8 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.93 168.55 8.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.841 0.353 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -110.71 152.68 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -166.74 -124.28 0.7 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.248 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.527 ' CZ2' ' HB2' ' A' ' 35' ' ' TRP . 1.6 t-105 -99.2 145.5 27.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 110.678 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.907 ' O ' HD22 ' A' ' 17' ' ' LEU . 3.6 p90 -58.51 112.21 4.64 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.155 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.826 ' HA ' HD13 ' A' ' 17' ' ' LEU . 91.9 Cg_endo -88.16 16.58 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.736 2.29 . . . . 0.0 112.598 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -56.47 -6.8 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.477 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.656 ' OD1' HD21 ' A' ' 17' ' ' LEU . 1.7 m120 -42.45 -30.88 0.37 Allowed 'General case' 0 C--N 1.342 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 66.6 m-85 -156.81 64.29 0.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.782 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.8 OUTLIER -139.48 163.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.659 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -104.5 117.52 34.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.24 137.01 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.38 116.05 26.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.308 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.6 73.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.945 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.678 0.275 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.538 ' HG2' ' HD2' ' A' ' 24' ' ' ARG . 97.8 Cg_endo -84.98 -164.66 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.72 2.28 . . . . 0.0 112.766 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -121.89 152.75 39.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -107.88 120.6 42.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.277 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 25' ' ' VAL . 75.1 t -77.56 151.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 111.692 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.15 151.22 45.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -91.16 139.62 30.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.895 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -135.14 148.18 49.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 m -87.86 128.26 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -119.73 -169.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 73.4 mt-10 -81.89 176.76 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.713 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.8 -154.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.668 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 5.6 mm-40 -50.46 105.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 122.124 0.964 . . . . 0.0 110.682 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 21.2 t0 154.76 -54.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.229 -1.805 . . . . 0.0 107.533 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.721 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.53 150.43 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.943 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.95 HD23 ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -121.53 150.65 41.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 p -70.69 150.13 46.27 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.499 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.755 HD22 ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.69 150.72 20.17 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.207 0.527 . . . . 0.0 111.389 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 23' ' ' SER . 3.3 t -69.15 161.08 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.142 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.918 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -95.7 -39.21 10.0 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.162 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 62.75 0.3 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.753 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.73 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -149.19 176.0 10.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.731 0.3 . . . . 0.0 110.703 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 2' ' ' PRO . 4.4 mmt85 -98.13 148.31 23.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.507 . . . . 0.0 111.54 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 5' ' ' VAL . 18.9 t -126.73 166.45 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 39' ' ' SER . 7.0 p -80.39 139.46 36.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 54' ' ' GLU . 7.2 p -54.12 128.05 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.517 0.675 . . . . 0.0 111.362 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.415 ' HE3' ' HB3' ' A' ' 28' ' ' MET . 45.6 mmm -64.35 -176.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.997 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -105.53 159.91 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.671 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -86.08 96.54 9.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -106.74 157.87 17.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.356 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 t -85.79 -27.67 25.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.62 164.65 12.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -19.83 44.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.654 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -80.02 91.84 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -90.03 128.66 36.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.09 149.84 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -168.93 176.74 43.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.554 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.4 OUTLIER -124.88 156.5 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.264 0.554 . . . . 0.0 111.493 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -149.25 145.57 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.91 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -59.35 86.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.471 . . . . 0.0 110.613 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.74 -39.25 0.74 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -169.84 177.45 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.897 0.38 . . . . 0.0 111.223 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.4 mp -124.59 156.94 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.829 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 17' ' ' LEU . . . 162.76 -153.86 24.6 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.078 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.523 ' N ' HD21 ' A' ' 17' ' ' LEU . 6.1 m-90 -99.37 130.21 45.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.761 0.315 . . . . 0.0 111.07 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.95 ' CE1' HD23 ' A' ' 17' ' ' LEU . 84.2 m-85 -124.53 132.33 24.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.755 ' HD2' HD22 ' A' ' 19' ' ' LEU . 9.3 Cg_exo -71.17 105.81 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.548 2.165 . . . . 0.0 112.909 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.461 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 t -60.23 -7.87 2.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.2 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.45 -28.42 0.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.475 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -147.76 63.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.414 178.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.2 m -139.36 152.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.145 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 8.6 tp -115.41 116.79 28.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -106.35 136.92 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.81 117.22 30.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.005 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.54 84.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.242 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 t0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.974 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.62 0.248 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.59 -176.0 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.72 2.28 . . . . 0.0 112.047 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -111.31 153.51 25.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.549 ' HD2' HD23 ' A' ' 53' ' ' LEU . 1.2 m-30 -108.1 116.37 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 23' ' ' SER . 43.6 t -82.4 142.01 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.819 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -92.23 -96.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.103 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.15 148.69 24.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.174 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -86.45 141.01 29.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.449 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 27.6 t80 -135.44 139.45 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.624 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.4 m -88.65 113.15 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.327 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.5 117.87 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 111.338 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.709 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.13 173.49 16.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.382 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.709 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -53.5 107.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.473 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER 85.16 15.76 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -127.23 144.0 51.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -128.89 151.35 49.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.352 0.596 . . . . 0.0 111.877 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 p -88.3 148.22 24.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 48' ' ' PRO . 1.8 mt -94.19 150.68 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.367 0.604 . . . . 0.0 111.563 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -97.26 165.29 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.571 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.594 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -103.46 100.78 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.318 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.23 15.15 78.82 Favored Glycine 0 C--N 1.319 -0.382 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.632 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -86.54 176.43 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.048 0.424 . . . . 0.0 110.827 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mmt-85 -120.82 148.61 43.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 111.658 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 39' ' ' SER . 4.7 t -124.92 165.27 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.052 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 25' ' ' VAL . 2.6 p -81.68 139.57 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.0 p -54.13 101.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 0.0 110.613 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.416 ' HG2' ' HB3' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -49.03 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.588 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.7 pt-20 -95.05 134.56 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.733 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -66.21 96.98 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.957 0.408 . . . . 0.0 110.489 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.8 149.24 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.721 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -93.34 -29.05 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.127 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.67 170.3 9.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.17 -22.2 9.55 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.987 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -79.75 133.19 36.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.585 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -134.36 125.35 27.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.037 0.446 . . . . 0.0 111.621 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -106.56 150.38 26.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.796 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.14 -169.96 33.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.945 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.561 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -129.36 156.75 43.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.31 0.576 . . . . 0.0 111.588 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' A' ' 25' ' ' VAL . 77.2 t80 -139.38 145.55 39.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.918 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -59.56 86.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 110.62 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 148.04 -32.26 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.395 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -169.92 170.86 7.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 111.429 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.5 mp -119.04 158.34 20.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 160.01 -125.53 1.49 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.196 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.644 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -98.55 146.87 25.35 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 120.504 0.193 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -73.75 144.2 82.67 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.937 0.398 . . . . 0.0 111.807 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' O ' HG13 ' A' ' 52' ' ' VAL . 86.1 Cg_endo -94.64 33.99 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.262 2.642 . . . . 0.0 112.145 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -34.45 -28.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 m-20 -41.66 -28.96 0.16 Allowed 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -160.58 64.89 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 110.206 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.63 163.34 28.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.397 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 4' ' ' PHE . 8.5 tp -128.65 117.28 20.93 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.917 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -106.08 134.98 48.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.39 . . . . 0.0 111.792 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' ' CE2' ' A' ' 4' ' ' PHE . 1.7 mt-10 -103.27 115.97 31.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.75 85.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.274 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.55 0.214 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.17 -175.66 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.878 2.385 . . . . 0.0 112.572 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -97.51 171.34 8.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.192 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.662 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.9 t80 -127.38 119.22 25.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.945 0.403 . . . . 0.0 111.537 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 25' ' ' VAL . 37.2 t -73.9 135.98 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.849 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -83.3 -72.2 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.55 150.11 35.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.56 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.83 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -88.21 132.11 34.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.003 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 55.5 t80 -134.74 148.01 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.07 141.35 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 16' ' ' GLU . . . -138.79 -167.89 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -81.47 176.98 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.822 -179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.69 -154.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.084 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 15.4 mm-40 -50.29 105.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 122.127 0.965 . . . . 0.0 110.659 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 4.0 t70 152.45 -55.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.282 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -128.62 149.96 50.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.805 177.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -129.59 150.74 50.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 p -66.16 149.89 49.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.956 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 47' ' ' PHE . 2.4 mt -93.3 150.8 20.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.214 0.53 . . . . 0.0 111.309 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.844 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.5 t -76.08 161.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.995 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.83 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 mttt -90.18 -42.43 11.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.166 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.25 62.52 0.28 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.898 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.844 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -136.06 -170.07 2.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.625 -0.288 . . . . 0.0 110.651 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -120.43 132.26 55.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.264 0.554 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 5' ' ' VAL . 21.4 t -110.56 166.57 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.566 HG21 ' HB2' ' A' ' 39' ' ' SER . 11.6 p -80.27 139.21 36.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.736 0.303 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.634 HG23 ' CG ' ' A' ' 54' ' ' GLU . 11.0 p -54.27 122.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.571 0.7 . . . . 0.0 111.436 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.426 ' HE1' ' H ' ' A' ' 47' ' ' PHE . 75.7 mmm -54.12 -176.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.0 pt-20 -111.24 140.12 46.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -69.64 96.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.53 154.12 21.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.327 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.0 t -93.36 -29.61 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.0 167.86 12.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.932 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.24 -16.3 53.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.97 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.47 96.15 7.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CE3' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -89.98 125.56 35.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.095 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.65 149.73 21.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.53 -173.19 35.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.566 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.3 OUTLIER -135.11 144.27 47.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.156 0.503 . . . . 0.0 111.282 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -140.87 145.55 36.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.082 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.51 86.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.142 0.496 . . . . 0.0 110.371 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 156.15 -40.77 0.58 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.066 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -169.98 162.16 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.7 mp -110.98 156.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 153.98 -137.56 5.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.617 ' O ' HD21 ' A' ' 17' ' ' LEU . 31.4 m-90 -99.26 145.42 27.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' HD22 ' A' ' 19' ' ' LEU . 1.2 t80 -141.59 119.92 7.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 19' ' ' LEU . 84.9 Cg_exo -50.6 88.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.832 2.355 . . . . 0.0 113.136 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.504 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -60.23 -12.24 8.34 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.205 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.75 -23.89 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.189 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -145.57 63.87 1.26 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.438 0.637 . . . . 0.0 110.571 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.504 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.5 m -138.71 151.18 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.214 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.662 HD23 ' CD2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -106.57 117.68 34.67 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.634 ' CG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -105.31 133.92 49.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.477 . . . . 0.0 111.872 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -120.34 117.32 27.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.371 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.73 82.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 0.0 111.196 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.865 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ILE . . . . . 0.794 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.624 0.25 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.52 -165.91 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.604 2.203 . . . . 0.0 112.143 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.34 159.04 28.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.45 117.48 32.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.595 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 20' ' ' VAL . 21.2 t -87.24 148.71 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -106.0 -75.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.14 156.92 16.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.783 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . . . -105.58 147.45 28.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.551 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.425 ' N ' ' HB2' ' A' ' 19' ' ' LEU . 6.4 t80 -135.5 135.85 40.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.9 m -88.89 108.23 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.266 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 162.14 88.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 116.59 20.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.137 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.17 149.46 22.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.354 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 pt-20 -54.16 106.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 36.2 t70 124.69 -31.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.932 0.77 . . . . 0.0 110.364 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 9.5 pt-20 -108.34 149.94 28.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.614 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.927 HD23 ' CE3' ' A' ' 46' ' ' TRP . 3.2 pp -107.56 131.94 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.703 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 54.4 p -106.7 146.96 30.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.535 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 50' ' ' ASN . 3.0 mm? -95.38 149.68 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.309 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' H ' HG11 ' A' ' 5' ' ' VAL . 2.0 t -94.85 164.68 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.215 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.783 ' HA ' ' HB2' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -73.3 -52.12 15.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.31 27.35 0.12 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.779 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.408 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -95.74 171.38 8.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -101.31 148.71 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 40' ' ' TYR . 25.9 t -124.94 165.26 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.533 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.4 p -81.24 139.01 35.73 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.4 p -54.84 118.48 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.369 0.604 . . . . 0.0 111.216 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.471 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -60.55 -175.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.17 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -95.51 161.88 13.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.138 -179.21 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -126.35 99.47 5.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.861 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.26 157.97 17.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -59.89 -26.39 65.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.932 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.84 169.15 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.931 0.396 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 36' ' ' TRP . . . -74.18 -7.63 77.54 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.255 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -86.49 133.16 33.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.992 0.396 . . . . 0.0 110.925 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 10.6 m-90 -141.12 126.13 18.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.37 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.4 149.05 24.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.076 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -134.07 158.43 23.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.852 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -111.07 153.35 25.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CE2' HG22 ' A' ' 25' ' ' VAL . 8.1 m-85 -122.8 145.03 48.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.94 86.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.21 -15.32 7.3 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.568 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.764 ' C ' HD12 ' A' ' 44' ' ' ILE . 7.0 pt20 -159.25 174.83 14.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.292 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.764 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -136.96 156.83 35.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . -176.05 -146.18 5.85 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CE3' HD23 ' A' ' 17' ' ' LEU . 2.1 t90 -99.3 146.36 26.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.961 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.901 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -55.73 113.24 5.32 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 17' ' ' LEU . 74.0 Cg_endo -94.49 37.04 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.091 2.527 . . . . 0.0 111.637 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.587 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -53.55 -9.6 0.21 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 19' ' ' LEU . 3.3 m-20 -42.35 -30.43 0.33 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 91.3 m-85 -157.81 64.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.209 0.528 . . . . 0.0 109.745 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -139.01 163.46 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.476 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 18.2 tp -114.46 116.92 29.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.705 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.62 ' OE1' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -106.54 137.03 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.912 0.387 . . . . 0.0 112.009 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.794 ' O ' HD13 ' A' ' 1' ' ' ILE . 0.6 OUTLIER -117.26 115.83 26.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG23 ' OE1' ' A' ' 54' ' ' GLU . 56.6 t -96.43 80.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.181 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.88 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.557 0.218 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.95 -170.75 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -98.0 170.93 8.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 53' ' ' LEU . 76.2 t80 -131.35 130.05 42.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.912 0.387 . . . . 0.0 111.729 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 19' ' ' LEU . 35.1 t -85.12 135.74 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -86.79 -47.85 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.504 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.01 150.63 44.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -82.33 139.88 33.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . 6.6 t80 -135.67 125.09 24.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.1 m -88.79 108.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.776 ' HB1' ' OE2' ' A' ' 16' ' ' GLU . . . -178.57 104.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.3 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.49 117.58 22.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.289 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.737 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.3 175.24 14.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.392 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.737 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 19.3 pt-20 -53.62 108.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.384 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER 87.13 10.96 0.14 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.776 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -127.25 137.75 52.94 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.998 0.428 . . . . 0.0 110.721 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.73 143.42 50.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -76.86 147.33 37.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD21 ' CB ' ' A' ' 48' ' ' PRO . 3.8 mm? -95.24 150.5 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.127 0.489 . . . . 0.0 111.61 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 23' ' ' SER . 0.9 OUTLIER -91.73 152.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.732 ' HE2' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.22 -42.4 95.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.87 24.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.267 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.782 ' HB2' HG11 ' A' ' 20' ' ' VAL . 13.8 t -78.12 -171.63 2.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.101 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -118.85 148.65 42.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.058 0.456 . . . . 0.0 111.235 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG13 ' CG ' ' A' ' 40' ' ' TYR . 42.6 t -121.44 165.52 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.586 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.561 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -80.93 139.95 35.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.7 p -53.68 90.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 110.55 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.6 mpp? -57.8 -175.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.688 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HB2' ' CD1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -95.93 161.19 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.011 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -135.29 96.69 3.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.947 0.403 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' CE2' ' A' ' 36' ' ' TRP . 25.0 t -107.14 157.68 17.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.178 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -56.57 -43.96 80.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.8 167.87 20.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.45 -21.02 63.01 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.966 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -82.12 104.59 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.595 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -160.98 133.94 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 3.9 mtt180 -111.34 130.04 55.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CG ' ' A' ' 28' ' ' MET . . . -102.73 -160.61 25.79 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.555 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -134.63 152.74 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.455 0.645 . . . . 0.0 111.947 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.689 ' CE1' HD22 ' A' ' 17' ' ' LEU . 14.3 m-85 -132.0 144.84 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.813 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -60.9 86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.69 -20.36 4.36 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.711 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.8 pt20 -169.68 165.86 9.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -117.54 159.41 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.074 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.449 ' HA2' ' NE ' ' A' ' 37' ' ' ARG . . . -175.47 -151.67 8.81 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.385 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' O ' HD21 ' A' ' 17' ' ' LEU . 69.0 t90 -97.36 130.08 44.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.2 114.29 10.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.698 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.907 ' CB ' HD21 ' A' ' 19' ' ' LEU . 81.6 Cg_endo -90.16 49.1 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.999 2.466 . . . . 0.0 111.711 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.544 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -37.05 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.9 m120 -42.37 -28.31 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.727 0.299 . . . . 0.0 111.418 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 61.4 m-85 -156.75 64.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.161 0.505 . . . . 0.0 109.944 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -138.91 163.32 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.648 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -126.53 116.78 21.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 56' ' ' VAL . 1.5 tt0 -106.45 127.06 53.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.871 0.367 . . . . 0.0 111.712 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.64 116.01 30.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.504 HG22 ' OE2' ' A' ' 54' ' ' GLU . 21.4 t -80.17 80.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.843 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.542 0.211 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.35 -167.43 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.715 2.277 . . . . 0.0 112.287 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -120.42 157.79 28.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 6.3 m-85 -109.81 116.29 31.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 20' ' ' VAL . 38.6 t -84.46 152.16 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.692 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 14.2 mtpt -111.53 -48.77 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 157.07 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.63 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.23 143.96 29.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.625 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 t80 -135.72 135.88 40.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.0 m -88.66 108.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.306 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.82 107.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.39 117.15 21.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 111.151 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.35 159.74 39.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.151 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.643 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 9.9 pt-20 -54.06 106.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.9 t0 97.47 0.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.961 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.35 129.46 47.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.7 pt? -127.51 142.7 51.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -72.21 147.16 46.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.944 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.625 HD12 ' HB2' ' A' ' 9' ' ' TYR . 5.0 mt -95.29 151.02 19.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.0 111.688 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.72 165.2 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.188 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.7 105.15 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.775 0.797 . . . . 0.0 111.295 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.57 18.58 73.9 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.375 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -97.91 -178.45 4.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -120.37 148.4 43.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.15 0.5 . . . . 0.0 111.25 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 40' ' ' TYR . 4.0 t -120.83 166.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.832 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 5.5 p -80.27 139.49 36.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.9 p -54.14 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.802 0.81 . . . . 0.0 111.651 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.493 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -51.93 -175.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.851 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.94 152.39 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.271 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.79 96.5 10.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.694 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 36' ' ' TRP . 13.0 t -99.42 143.16 29.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.827 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 -44.79 8.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.527 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -146.58 106.16 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.686 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.45 -134.55 5.22 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.841 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -104.53 133.95 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.817 0.341 . . . . 0.0 110.609 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -88.61 125.25 34.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 111.204 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -93.66 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.69 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -168.83 167.63 40.54 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.071 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.623 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.8 m -125.33 156.38 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 111.448 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.548 ' HB2' HG13 ' A' ' 25' ' ' VAL . 24.1 t80 -149.07 144.94 27.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.227 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.06 86.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.81 -27.43 1.46 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.395 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 44' ' ' ILE . 6.9 pt20 -169.74 167.52 9.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 111.58 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.1 mp -136.14 156.74 37.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.939 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 147.38 -100.39 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.561 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -99.21 146.29 26.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.48 148.67 74.03 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 52' ' ' VAL . 89.7 Cg_endo -93.12 32.21 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.062 2.508 . . . . 0.0 111.888 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -39.33 -21.63 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.511 ' CB ' HD11 ' A' ' 19' ' ' LEU . 1.7 m120 -41.31 -31.07 0.2 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 63.8 m-85 -160.69 64.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.864 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.77 163.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.223 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -124.2 117.84 25.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.734 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.4 129.87 53.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 0.0 111.768 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.53 138.17 32.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.748 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.88 75.81 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.267 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.878 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.537 0.208 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 92.8 Cg_endo -86.05 -167.13 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.602 2.201 . . . . 0.0 112.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -112.7 155.39 24.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 m-85 -109.2 116.38 31.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.673 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 23' ' ' SER . 59.9 t -77.63 158.62 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.687 0.28 . . . . 0.0 110.752 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 5' ' ' VAL . 13.4 mtpt -114.54 -69.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.806 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.2 157.05 25.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.75 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -96.98 138.87 33.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.201 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 19' ' ' LEU . 3.1 t80 -136.0 131.68 35.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 10' ' ' VAL . 3.2 m -88.72 108.54 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 95.49 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.16 117.02 28.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.282 0.563 . . . . 0.0 110.921 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.17 156.65 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.173 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 6.8 pt-20 -54.04 106.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.7 t70 105.15 -17.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.922 0.764 . . . . 0.0 110.963 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -114.14 141.33 47.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.966 HD21 ' O ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -129.44 149.36 51.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.03 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 p -77.68 148.11 35.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 48' ' ' PRO . 3.5 mm? -94.42 148.96 21.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.04 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 23' ' ' SER . 1.9 t -95.81 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.323 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -67.23 -36.12 81.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.189 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.02 32.09 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.265 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -79.09 -176.93 5.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.322 . . . . 0.0 110.894 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' NE ' ' CZ ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -120.45 148.73 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' CD2' ' A' ' 40' ' ' TYR . 40.6 t -119.89 165.85 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.687 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.83 HG23 ' HA ' ' A' ' 40' ' ' TYR . 1.6 p -80.41 140.79 35.84 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.3 p -52.68 97.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 122.06 0.933 . . . . 0.0 110.312 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -48.72 -176.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.768 -1.56 . . . . 0.0 112.744 -178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 2.6 pt-20 -96.0 161.96 13.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.754 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.19 144.28 36.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -104.53 145.72 29.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.787 0.327 . . . . 0.0 110.781 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -93.47 -45.42 7.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -147.42 97.38 2.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.852 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.34 -41.68 0.13 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.302 0.881 . . . . 0.0 115.302 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' TRP . 4.4 p-90 -79.31 113.13 17.2 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.983 0.892 . . . . 0.0 112.08 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.548 ' HB3' ' CG ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -116.97 126.18 52.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.661 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' MET . 0.0 OUTLIER -104.74 150.03 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -149.39 171.82 29.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.107 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.634 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.6 m -131.77 156.92 45.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.394 0.616 . . . . 0.0 112.276 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.83 ' HA ' HG23 ' A' ' 26' ' ' THR . 1.2 m-85 -136.68 144.84 44.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.46 86.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.889 0.376 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.18 -13.77 5.97 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.138 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.733 ' C ' HD12 ' A' ' 44' ' ' ILE . 5.4 pt20 -168.88 152.4 5.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.072 0.436 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -125.19 158.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 177.01 -144.47 6.81 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.618 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.966 ' O ' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -98.76 138.1 36.4 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 110.773 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -54.29 138.5 58.0 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HB2' HD11 ' A' ' 19' ' ' LEU . 60.9 Cg_endo -99.86 28.96 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.976 3.118 . . . . 0.0 111.821 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -30.9 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 2.5 m120 -41.4 -32.43 0.32 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 69.0 m-85 -158.31 64.62 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 0.0 110.018 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.77 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.05 163.54 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.619 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 10.8 tp -129.23 117.19 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.958 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.1 131.47 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.715 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 2' ' ' PRO . 1.4 mt-10 -102.25 121.13 41.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.373 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.62 83.7 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.954 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ILE . . . . . 0.666 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.519 0.199 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.35 -166.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.682 2.255 . . . . 0.0 112.264 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.29 163.87 18.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.122 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -113.68 116.13 28.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.716 0.293 . . . . 0.0 111.086 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.681 HG11 ' H ' ' A' ' 20' ' ' VAL . 14.9 t -87.68 145.38 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.7 -81.46 0.54 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.858 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.74 154.68 19.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.864 0.364 . . . . 0.0 111.427 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.683 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -115.11 145.55 42.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.862 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 5.3 t80 -135.6 139.45 43.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.494 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 7.6 m -88.75 108.48 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 169.26 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.244 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -127.74 116.73 20.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 110.511 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.05 153.44 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.862 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.51 106.32 0.28 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 11.8 t70 118.45 -28.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.481 0.712 . . . . 0.0 110.624 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 13' ' ' ARG . 12.8 pt-20 -106.04 150.04 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.207 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -127.01 121.03 30.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 11.3 p -80.41 147.07 31.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.769 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -95.56 151.13 19.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 0.0 111.479 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.683 ' C ' ' HB2' ' A' ' 8' ' ' ALA . 2.3 t -91.52 164.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.704 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.2 -39.01 41.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.422 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.79 33.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.81 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.632 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -102.59 165.87 10.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.804 0.335 . . . . 0.0 110.804 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.12 148.61 23.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 40' ' ' TYR . 3.9 t -120.21 164.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.254 0.549 . . . . 0.0 112.072 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 25' ' ' VAL . 3.4 p -81.68 140.73 34.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.6 p -53.45 91.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 122.094 0.95 . . . . 0.0 110.577 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.531 ' CB ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -47.3 -175.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.659 -1.61 . . . . 0.0 113.458 -178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 11.5 pt-20 -95.75 161.3 14.08 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.088 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -109.05 96.15 6.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 p -97.41 158.13 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.128 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -90.44 -6.33 55.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.404 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -104.26 175.45 5.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.011 0.434 . . . . 0.0 111.044 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.0 74.28 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 35' ' ' TRP . 42.6 p-90 -79.99 98.94 7.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.364 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -89.96 125.07 35.24 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -96.25 150.19 20.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 28' ' ' MET . . . -165.88 -176.46 37.25 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.94 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -134.94 142.5 46.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.845 0.322 . . . . 0.0 111.06 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.593 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -137.37 144.4 42.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.55 90.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.45 -27.46 2.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.093 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.705 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.1 pt20 -169.72 154.51 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -120.83 158.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.463 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 155.13 -128.3 2.27 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 17' ' ' LEU . 25.5 m-90 -99.02 140.44 33.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.842 ' O ' HD22 ' A' ' 17' ' ' LEU . 49.5 p90 -91.77 141.9 26.08 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.802 ' HA ' HD13 ' A' ' 17' ' ' LEU . 41.6 Cg_endo -92.0 58.83 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.512 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.429 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -49.81 -19.57 0.68 Allowed 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -42.86 -27.88 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.663 0.268 . . . . 0.0 111.662 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -154.42 64.98 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.09 163.36 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -113.43 116.97 30.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.39 136.17 46.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 1' ' ' ILE . 1.6 mt-10 -118.12 116.0 25.96 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.22 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.91 74.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 111.324 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.836 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.672 0.273 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.53 -165.9 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.555 2.17 . . . . 0.0 111.983 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.733 ' HB2' HG12 ' A' ' 27' ' ' VAL . . . -111.1 164.21 13.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.394 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 28.7 t80 -112.27 116.56 30.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' HG23 ' A' ' 25' ' ' VAL . 24.3 t -83.31 142.61 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -108.95 -68.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 156.97 17.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.484 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.557 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -113.96 138.77 49.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.331 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.801 ' HB2' HD12 ' A' ' 19' ' ' LEU . 8.0 t80 -135.44 130.05 34.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.567 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 10' ' ' VAL . 5.7 m -101.01 108.32 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.254 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 16' ' ' GLU . . . 179.67 114.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.07 117.08 27.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.272 0.558 . . . . 0.0 111.131 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.599 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.27 158.46 37.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.228 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.599 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -54.1 106.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.0 t0 95.64 9.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.934 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.31 137.52 52.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -129.91 150.89 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.79 135.12 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.98 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 9' ' ' TYR . 2.7 mt -95.36 150.75 19.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.004 0.43 . . . . 0.0 111.676 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.794 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.8 t -88.93 164.58 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.92 -35.43 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.027 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.31 67.92 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.605 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.794 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.13 -170.22 2.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.723 0.297 . . . . 0.0 110.713 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -120.53 140.75 51.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.147 0.499 . . . . 0.0 111.455 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 40' ' ' TYR . 25.4 t -136.18 158.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 30.3 p -97.13 95.5 7.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.569 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 47' ' ' PHE . 10.1 p -104.87 101.99 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.007 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.87 101.33 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.226 0.536 . . . . 0.0 111.635 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 29.1 tp10 -140.78 161.48 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.303 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 4.0 mttm -133.48 95.23 3.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.152 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.7 t -108.02 157.99 17.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.19 -6.6 59.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.804 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.99 173.19 6.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.99 76.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.997 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -80.06 127.9 32.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.4 . . . . 0.0 110.978 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 m0 -109.85 149.6 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.375 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -92.68 151.06 20.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.46 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -145.62 157.56 27.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.595 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 44' ' ' ILE . 13.9 m -121.14 152.47 38.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.3 137.04 40.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.86 86.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.49 -15.58 5.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.006 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.781 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -169.03 157.78 8.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.39 . . . . 0.0 110.375 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -133.85 158.24 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.172 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 169.16 -112.2 0.46 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.815 ' O ' HD22 ' A' ' 17' ' ' LEU . 4.4 t90 -98.78 145.43 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.342 . . . . 0.0 111.105 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.77 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -64.54 128.91 93.93 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.479 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.83 ' HA ' HD21 ' A' ' 17' ' ' LEU . 68.2 Cg_endo -89.16 12.99 2.55 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.902 2.401 . . . . 0.0 113.115 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.825 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -45.02 -16.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 2.8 m120 -41.53 -33.38 0.44 Allowed 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.106 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 65.6 m-85 -158.62 64.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.111 0.481 . . . . 0.0 109.817 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.34 163.52 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.147 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 42.9 tp -101.99 117.62 35.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.303 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.93 136.61 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.216 0.532 . . . . 0.0 112.287 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.06 115.87 19.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.066 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -83.87 78.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.233 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.4 t0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.865 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.608 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -85.99 -166.23 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.737 2.291 . . . . 0.0 112.54 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -129.4 156.76 43.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -107.77 116.03 31.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.383 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 45.8 t -82.09 149.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.459 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -106.18 -42.2 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 156.88 36.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -109.05 143.33 38.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -128.48 120.27 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.222 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.8 m -88.63 108.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 161.68 110.42 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.061 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -123.08 113.9 19.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.408 0.623 . . . . 0.0 110.105 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -159.46 155.07 25.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.541 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 1.0 OUTLIER -63.12 105.43 0.7 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.488 178.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 13.7 t0 134.6 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.098 0.559 . . . . 0.0 111.585 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -97.52 150.3 21.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.444 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 47' ' ' PHE . 2.0 pp -111.62 120.84 43.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.314 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.545 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.6 p -85.7 147.18 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 17' ' ' LEU . 10.8 mt -126.4 151.3 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.961 0.41 . . . . 0.0 111.641 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.4 t -96.0 162.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.648 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -81.0 -33.06 33.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.487 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.44 63.76 0.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.819 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.681 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -140.32 -178.23 5.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.666 0.27 . . . . 0.0 110.553 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -120.27 126.59 50.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.347 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.704 HG22 ' CE2' ' A' ' 40' ' ' TYR . 45.5 t -111.53 162.01 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.102 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 0.6 OUTLIER -105.71 95.89 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.487 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.2 p -104.92 113.45 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.89 100.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 112.471 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 40.6 tp10 -140.95 161.56 37.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.189 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.61 94.95 2.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.665 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.37 157.45 18.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.374 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.4 t -93.27 -46.68 7.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.331 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.4 97.59 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.453 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 159.33 -147.04 13.84 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.134 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -79.75 134.03 36.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.395 -0.903 . . . . 0.0 112.844 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -96.42 131.14 43.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.18 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -99.49 151.09 21.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.135 0.493 . . . . 0.0 111.613 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.73 165.28 26.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.718 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -116.86 156.82 26.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.69 0.281 . . . . 0.0 110.433 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CE2' HG22 ' A' ' 25' ' ' VAL . 7.7 t80 -149.16 144.99 26.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 1.7 p-10 -59.75 86.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.58 -34.46 1.8 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.93 168.55 8.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.841 0.353 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -110.71 152.68 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -166.74 -124.28 0.7 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.248 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.527 ' CZ2' ' HB2' ' A' ' 35' ' ' TRP . 1.6 t-105 -99.2 145.5 27.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 110.678 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.907 ' O ' HD22 ' A' ' 17' ' ' LEU . 3.6 p90 -58.51 112.21 4.64 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.155 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.826 ' HA ' HD13 ' A' ' 17' ' ' LEU . 91.9 Cg_endo -88.16 16.58 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.736 2.29 . . . . 0.0 112.598 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -56.47 -6.8 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.477 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.656 ' OD1' HD21 ' A' ' 17' ' ' LEU . 1.7 m120 -42.45 -30.88 0.37 Allowed 'General case' 0 C--N 1.342 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 66.6 m-85 -156.81 64.29 0.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.782 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.8 OUTLIER -139.48 163.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.659 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -104.5 117.52 34.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.24 137.01 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.38 116.05 26.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.308 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.6 73.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.945 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.678 0.275 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.538 ' HG2' ' HD2' ' A' ' 24' ' ' ARG . 97.8 Cg_endo -84.98 -164.66 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.72 2.28 . . . . 0.0 112.766 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -121.89 152.75 39.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -107.88 120.6 42.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.277 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 25' ' ' VAL . 75.1 t -77.56 151.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 111.692 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.15 151.22 45.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -91.16 139.62 30.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.895 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -135.14 148.18 49.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 m -87.86 128.26 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -119.73 -169.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 73.4 mt-10 -81.89 176.76 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.713 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.8 -154.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.668 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 5.6 mm-40 -50.46 105.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 122.124 0.964 . . . . 0.0 110.682 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 21.2 t0 154.76 -54.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.229 -1.805 . . . . 0.0 107.533 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.721 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.53 150.43 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.943 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.95 HD23 ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -121.53 150.65 41.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 p -70.69 150.13 46.27 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.499 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.755 HD22 ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.69 150.72 20.17 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.207 0.527 . . . . 0.0 111.389 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 23' ' ' SER . 3.3 t -69.15 161.08 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.142 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.918 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -95.7 -39.21 10.0 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.162 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 62.75 0.3 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.753 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.73 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -149.19 176.0 10.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.731 0.3 . . . . 0.0 110.703 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 2' ' ' PRO . 4.4 mmt85 -98.13 148.31 23.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.507 . . . . 0.0 111.54 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 5' ' ' VAL . 18.9 t -126.73 166.45 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 39' ' ' SER . 7.0 p -80.39 139.46 36.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 54' ' ' GLU . 7.2 p -54.12 128.05 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.517 0.675 . . . . 0.0 111.362 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.415 ' HE3' ' HB3' ' A' ' 28' ' ' MET . 45.6 mmm -64.35 -176.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.997 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -105.53 159.91 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.671 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -86.08 96.54 9.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -106.74 157.87 17.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.356 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 t -85.79 -27.67 25.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.62 164.65 12.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -19.83 44.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.654 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -80.02 91.84 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -90.03 128.66 36.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.09 149.84 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -168.93 176.74 43.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.554 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.4 OUTLIER -124.88 156.5 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.264 0.554 . . . . 0.0 111.493 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -149.25 145.57 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.91 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -59.35 86.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.471 . . . . 0.0 110.613 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.74 -39.25 0.74 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -169.84 177.45 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.897 0.38 . . . . 0.0 111.223 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.4 mp -124.59 156.94 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.829 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 17' ' ' LEU . . . 162.76 -153.86 24.6 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.078 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.523 ' N ' HD21 ' A' ' 17' ' ' LEU . 6.1 m-90 -99.37 130.21 45.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.761 0.315 . . . . 0.0 111.07 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.95 ' CE1' HD23 ' A' ' 17' ' ' LEU . 84.2 m-85 -124.53 132.33 24.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.755 ' HD2' HD22 ' A' ' 19' ' ' LEU . 9.3 Cg_exo -71.17 105.81 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.548 2.165 . . . . 0.0 112.909 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.461 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 t -60.23 -7.87 2.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.2 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.45 -28.42 0.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.475 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -147.76 63.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.414 178.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.2 m -139.36 152.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.145 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 8.6 tp -115.41 116.79 28.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -106.35 136.92 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.81 117.22 30.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.005 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.54 84.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.242 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 t0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.974 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.62 0.248 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.59 -176.0 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.72 2.28 . . . . 0.0 112.047 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -111.31 153.51 25.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.549 ' HD2' HD23 ' A' ' 53' ' ' LEU . 1.2 m-30 -108.1 116.37 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 23' ' ' SER . 43.6 t -82.4 142.01 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.819 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -92.23 -96.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.103 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.15 148.69 24.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.174 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -86.45 141.01 29.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.449 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 27.6 t80 -135.44 139.45 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.624 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.4 m -88.65 113.15 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.327 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.5 117.87 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 111.338 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.709 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.13 173.49 16.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.382 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.709 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -53.5 107.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.473 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER 85.16 15.76 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -127.23 144.0 51.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -128.89 151.35 49.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.352 0.596 . . . . 0.0 111.877 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 p -88.3 148.22 24.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 48' ' ' PRO . 1.8 mt -94.19 150.68 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.367 0.604 . . . . 0.0 111.563 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -97.26 165.29 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.571 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.594 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -103.46 100.78 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.318 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.23 15.15 78.82 Favored Glycine 0 C--N 1.319 -0.382 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.632 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -86.54 176.43 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.048 0.424 . . . . 0.0 110.827 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mmt-85 -120.82 148.61 43.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 111.658 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 39' ' ' SER . 4.7 t -124.92 165.27 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.052 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 25' ' ' VAL . 2.6 p -81.68 139.57 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.0 p -54.13 101.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 0.0 110.613 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.416 ' HG2' ' HB3' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -49.03 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.588 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.7 pt-20 -95.05 134.56 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.733 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -66.21 96.98 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.957 0.408 . . . . 0.0 110.489 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.8 149.24 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.721 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -93.34 -29.05 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.127 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.67 170.3 9.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.17 -22.2 9.55 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.987 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -79.75 133.19 36.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.585 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -134.36 125.35 27.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.037 0.446 . . . . 0.0 111.621 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -106.56 150.38 26.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.796 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.14 -169.96 33.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.945 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.561 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -129.36 156.75 43.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.31 0.576 . . . . 0.0 111.588 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' A' ' 25' ' ' VAL . 77.2 t80 -139.38 145.55 39.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.918 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -59.56 86.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 110.62 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 148.04 -32.26 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.395 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -169.92 170.86 7.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 111.429 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.5 mp -119.04 158.34 20.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 160.01 -125.53 1.49 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.196 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.644 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -98.55 146.87 25.35 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 120.504 0.193 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -73.75 144.2 82.67 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.937 0.398 . . . . 0.0 111.807 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' O ' HG13 ' A' ' 52' ' ' VAL . 86.1 Cg_endo -94.64 33.99 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.262 2.642 . . . . 0.0 112.145 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -34.45 -28.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 m-20 -41.66 -28.96 0.16 Allowed 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -160.58 64.89 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 110.206 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.63 163.34 28.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.397 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 4' ' ' PHE . 8.5 tp -128.65 117.28 20.93 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.917 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -106.08 134.98 48.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.39 . . . . 0.0 111.792 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' ' CE2' ' A' ' 4' ' ' PHE . 1.7 mt-10 -103.27 115.97 31.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.75 85.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.274 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.55 0.214 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.17 -175.66 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.878 2.385 . . . . 0.0 112.572 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -97.51 171.34 8.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.192 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.9 t80 -127.38 119.22 25.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.945 0.403 . . . . 0.0 111.537 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 25' ' ' VAL . 37.2 t -73.9 135.98 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.849 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -83.3 -72.2 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.55 150.11 35.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.56 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.83 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -88.21 132.11 34.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.003 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 55.5 t80 -134.74 148.01 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.07 141.35 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 16' ' ' GLU . . . -138.79 -167.89 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -81.47 176.98 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.822 -179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.69 -154.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.084 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 15.4 mm-40 -50.29 105.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 122.127 0.965 . . . . 0.0 110.659 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 4.0 t70 152.45 -55.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.282 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -128.62 149.96 50.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.805 177.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -129.59 150.74 50.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 p -66.16 149.89 49.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.956 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 47' ' ' PHE . 2.4 mt -93.3 150.8 20.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.214 0.53 . . . . 0.0 111.309 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.844 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.5 t -76.08 161.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.995 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.83 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 mttt -90.18 -42.43 11.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.166 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.25 62.52 0.28 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.898 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.844 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -136.06 -170.07 2.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.625 -0.288 . . . . 0.0 110.651 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -120.43 132.26 55.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.264 0.554 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 5' ' ' VAL . 21.4 t -110.56 166.57 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.566 HG21 ' HB2' ' A' ' 39' ' ' SER . 11.6 p -80.27 139.21 36.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.736 0.303 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.634 HG23 ' CG ' ' A' ' 54' ' ' GLU . 11.0 p -54.27 122.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.571 0.7 . . . . 0.0 111.436 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.426 ' HE1' ' H ' ' A' ' 47' ' ' PHE . 75.7 mmm -54.12 -176.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.0 pt-20 -111.24 140.12 46.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -69.64 96.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.53 154.12 21.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.327 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.0 t -93.36 -29.61 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.0 167.86 12.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.932 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.24 -16.3 53.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.97 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.47 96.15 7.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CE3' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -89.98 125.56 35.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.095 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.65 149.73 21.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.53 -173.19 35.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.566 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.3 OUTLIER -135.11 144.27 47.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.156 0.503 . . . . 0.0 111.282 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -140.87 145.55 36.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.082 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.51 86.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.142 0.496 . . . . 0.0 110.371 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 156.15 -40.77 0.58 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.066 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -169.98 162.16 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.7 mp -110.98 156.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 153.98 -137.56 5.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.617 ' O ' HD21 ' A' ' 17' ' ' LEU . 31.4 m-90 -99.26 145.42 27.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' HD22 ' A' ' 19' ' ' LEU . 1.2 t80 -141.59 119.92 7.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 19' ' ' LEU . 84.9 Cg_exo -50.6 88.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.832 2.355 . . . . 0.0 113.136 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.504 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -60.23 -12.24 8.34 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.205 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.75 -23.89 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.189 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -145.57 63.87 1.26 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.438 0.637 . . . . 0.0 110.571 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.504 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.5 m -138.71 151.18 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.214 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.662 HD23 ' CD2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -106.57 117.68 34.67 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.634 ' CG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -105.31 133.92 49.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.477 . . . . 0.0 111.872 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -120.34 117.32 27.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.371 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.73 82.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 0.0 111.196 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.865 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.794 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.624 0.25 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.52 -165.91 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.604 2.203 . . . . 0.0 112.143 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.34 159.04 28.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.45 117.48 32.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.595 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 20' ' ' VAL . 21.2 t -87.24 148.71 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -106.0 -75.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.14 156.92 16.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.783 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . . . -105.58 147.45 28.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.551 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.425 ' N ' ' HB2' ' A' ' 19' ' ' LEU . 6.4 t80 -135.5 135.85 40.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.9 m -88.89 108.23 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.266 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 162.14 88.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 116.59 20.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.137 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.17 149.46 22.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.354 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 pt-20 -54.16 106.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 36.2 t70 124.69 -31.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.932 0.77 . . . . 0.0 110.364 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 9.5 pt-20 -108.34 149.94 28.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.614 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.927 HD23 ' CE3' ' A' ' 46' ' ' TRP . 3.2 pp -107.56 131.94 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.703 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 54.4 p -106.7 146.96 30.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.535 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 50' ' ' ASN . 3.0 mm? -95.38 149.68 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.309 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' H ' HG11 ' A' ' 5' ' ' VAL . 2.0 t -94.85 164.68 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.215 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.783 ' HA ' ' HB2' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -73.3 -52.12 15.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.31 27.35 0.12 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.779 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.408 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -95.74 171.38 8.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -101.31 148.71 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 40' ' ' TYR . 25.9 t -124.94 165.26 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.533 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.4 p -81.24 139.01 35.73 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.4 p -54.84 118.48 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.369 0.604 . . . . 0.0 111.216 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.471 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -60.55 -175.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.17 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -95.51 161.88 13.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.138 -179.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -126.35 99.47 5.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.861 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.26 157.97 17.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -59.89 -26.39 65.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.932 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.84 169.15 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.931 0.396 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 36' ' ' TRP . . . -74.18 -7.63 77.54 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.255 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -86.49 133.16 33.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.992 0.396 . . . . 0.0 110.925 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 10.6 m-90 -141.12 126.13 18.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.37 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.4 149.05 24.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.076 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -134.07 158.43 23.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.852 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -111.07 153.35 25.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CE2' HG22 ' A' ' 25' ' ' VAL . 8.1 m-85 -122.8 145.03 48.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.94 86.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.21 -15.32 7.3 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.568 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.764 ' C ' HD12 ' A' ' 44' ' ' ILE . 7.0 pt20 -159.25 174.83 14.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.292 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.764 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -136.96 156.83 35.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . -176.05 -146.18 5.85 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CE3' HD23 ' A' ' 17' ' ' LEU . 2.1 t90 -99.3 146.36 26.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.961 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.901 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -55.73 113.24 5.32 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 17' ' ' LEU . 74.0 Cg_endo -94.49 37.04 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.091 2.527 . . . . 0.0 111.637 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.587 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -53.55 -9.6 0.21 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 19' ' ' LEU . 3.3 m-20 -42.35 -30.43 0.33 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 91.3 m-85 -157.81 64.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.209 0.528 . . . . 0.0 109.745 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -139.01 163.46 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.476 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 18.2 tp -114.46 116.92 29.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.705 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.62 ' OE1' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -106.54 137.03 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.912 0.387 . . . . 0.0 112.009 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.794 ' O ' HD13 ' A' ' 1' ' ' ILE . 0.6 OUTLIER -117.26 115.83 26.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG23 ' OE1' ' A' ' 54' ' ' GLU . 56.6 t -96.43 80.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.181 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.88 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.557 0.218 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.95 -170.75 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -98.0 170.93 8.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 53' ' ' LEU . 76.2 t80 -131.35 130.05 42.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.912 0.387 . . . . 0.0 111.729 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 19' ' ' LEU . 35.1 t -85.12 135.74 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -86.79 -47.85 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.504 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.01 150.63 44.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -82.33 139.88 33.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . 6.6 t80 -135.67 125.09 24.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.1 m -88.79 108.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.776 ' HB1' ' OE2' ' A' ' 16' ' ' GLU . . . -178.57 104.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.3 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.49 117.58 22.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.289 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.737 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.3 175.24 14.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.392 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.737 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 19.3 pt-20 -53.62 108.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.384 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER 87.13 10.96 0.14 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.776 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -127.25 137.75 52.94 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.998 0.428 . . . . 0.0 110.721 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.73 143.42 50.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -76.86 147.33 37.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD21 ' CB ' ' A' ' 48' ' ' PRO . 3.8 mm? -95.24 150.5 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.127 0.489 . . . . 0.0 111.61 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 23' ' ' SER . 0.9 OUTLIER -91.73 152.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.732 ' HE2' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.22 -42.4 95.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.87 24.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.267 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.782 ' HB2' HG11 ' A' ' 20' ' ' VAL . 13.8 t -78.12 -171.63 2.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.101 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -118.85 148.65 42.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.058 0.456 . . . . 0.0 111.235 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG13 ' CG ' ' A' ' 40' ' ' TYR . 42.6 t -121.44 165.52 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.586 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.561 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -80.93 139.95 35.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.7 p -53.68 90.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 110.55 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.6 mpp? -57.8 -175.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.688 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HB2' ' CD1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -95.93 161.19 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.011 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -135.29 96.69 3.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.947 0.403 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' CE2' ' A' ' 36' ' ' TRP . 25.0 t -107.14 157.68 17.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.178 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -56.57 -43.96 80.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.8 167.87 20.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.45 -21.02 63.01 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.966 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -82.12 104.59 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.595 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -160.98 133.94 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 3.9 mtt180 -111.34 130.04 55.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CG ' ' A' ' 28' ' ' MET . . . -102.73 -160.61 25.79 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.555 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -134.63 152.74 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.455 0.645 . . . . 0.0 111.947 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.689 ' CE1' HD22 ' A' ' 17' ' ' LEU . 14.3 m-85 -132.0 144.84 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.813 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -60.9 86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.69 -20.36 4.36 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.711 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.8 pt20 -169.68 165.86 9.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -117.54 159.41 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.074 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.449 ' HA2' ' NE ' ' A' ' 37' ' ' ARG . . . -175.47 -151.67 8.81 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.385 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.66 ' O ' HD21 ' A' ' 17' ' ' LEU . 69.0 t90 -97.36 130.08 44.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.2 114.29 10.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.698 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.907 ' CB ' HD21 ' A' ' 19' ' ' LEU . 81.6 Cg_endo -90.16 49.1 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.999 2.466 . . . . 0.0 111.711 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.544 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -37.05 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.9 m120 -42.37 -28.31 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.727 0.299 . . . . 0.0 111.418 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 61.4 m-85 -156.75 64.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.161 0.505 . . . . 0.0 109.944 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -138.91 163.32 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.648 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -126.53 116.78 21.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 56' ' ' VAL . 1.5 tt0 -106.45 127.06 53.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.871 0.367 . . . . 0.0 111.712 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.64 116.01 30.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.504 HG22 ' OE2' ' A' ' 54' ' ' GLU . 21.4 t -80.17 80.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.843 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.542 0.211 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.35 -167.43 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.715 2.277 . . . . 0.0 112.287 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -120.42 157.79 28.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 6.3 m-85 -109.81 116.29 31.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 20' ' ' VAL . 38.6 t -84.46 152.16 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.692 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 14.2 mtpt -111.53 -48.77 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 157.07 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.63 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.23 143.96 29.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.625 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 t80 -135.72 135.88 40.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.0 m -88.66 108.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.306 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.82 107.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.39 117.15 21.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 111.151 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.35 159.74 39.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.151 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.643 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 9.9 pt-20 -54.06 106.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.9 t0 97.47 0.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.961 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.35 129.46 47.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.7 pt? -127.51 142.7 51.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -72.21 147.16 46.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.944 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.625 HD12 ' HB2' ' A' ' 9' ' ' TYR . 5.0 mt -95.29 151.02 19.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.0 111.688 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.72 165.2 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.188 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.7 105.15 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.775 0.797 . . . . 0.0 111.295 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.57 18.58 73.9 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.375 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -97.91 -178.45 4.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -120.37 148.4 43.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.15 0.5 . . . . 0.0 111.25 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 40' ' ' TYR . 4.0 t -120.83 166.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.832 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 5.5 p -80.27 139.49 36.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.9 p -54.14 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.802 0.81 . . . . 0.0 111.651 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.493 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -51.93 -175.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.851 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.94 152.39 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.271 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.79 96.5 10.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.694 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 36' ' ' TRP . 13.0 t -99.42 143.16 29.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.827 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 -44.79 8.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.527 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -146.58 106.16 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.686 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.45 -134.55 5.22 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.841 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -104.53 133.95 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.817 0.341 . . . . 0.0 110.609 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -88.61 125.25 34.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 111.204 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -93.66 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.69 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -168.83 167.63 40.54 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.071 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.623 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.8 m -125.33 156.38 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 111.448 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.548 ' HB2' HG13 ' A' ' 25' ' ' VAL . 24.1 t80 -149.07 144.94 27.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.227 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.06 86.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.81 -27.43 1.46 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.395 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 44' ' ' ILE . 6.9 pt20 -169.74 167.52 9.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 111.58 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.1 mp -136.14 156.74 37.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.939 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 147.38 -100.39 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.561 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -99.21 146.29 26.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.48 148.67 74.03 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 52' ' ' VAL . 89.7 Cg_endo -93.12 32.21 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.062 2.508 . . . . 0.0 111.888 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -39.33 -21.63 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.511 ' CB ' HD11 ' A' ' 19' ' ' LEU . 1.7 m120 -41.31 -31.07 0.2 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 63.8 m-85 -160.69 64.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.864 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.77 163.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.223 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -124.2 117.84 25.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.734 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.4 129.87 53.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 0.0 111.768 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.53 138.17 32.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.748 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.88 75.81 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.267 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.878 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.537 0.208 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 92.8 Cg_endo -86.05 -167.13 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.602 2.201 . . . . 0.0 112.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -112.7 155.39 24.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 m-85 -109.2 116.38 31.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.673 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 23' ' ' SER . 59.9 t -77.63 158.62 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.687 0.28 . . . . 0.0 110.752 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 5' ' ' VAL . 13.4 mtpt -114.54 -69.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.806 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.2 157.05 25.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.75 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -96.98 138.87 33.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.201 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 19' ' ' LEU . 3.1 t80 -136.0 131.68 35.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 10' ' ' VAL . 3.2 m -88.72 108.54 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 95.49 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.16 117.02 28.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.282 0.563 . . . . 0.0 110.921 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.17 156.65 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.173 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 6.8 pt-20 -54.04 106.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.7 t70 105.15 -17.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.922 0.764 . . . . 0.0 110.963 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -114.14 141.33 47.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.966 HD21 ' O ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -129.44 149.36 51.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.03 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 p -77.68 148.11 35.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 48' ' ' PRO . 3.5 mm? -94.42 148.96 21.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.04 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 23' ' ' SER . 1.9 t -95.81 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.323 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -67.23 -36.12 81.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.189 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.02 32.09 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.265 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -79.09 -176.93 5.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.322 . . . . 0.0 110.894 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' NE ' ' CZ ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -120.45 148.73 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' CD2' ' A' ' 40' ' ' TYR . 40.6 t -119.89 165.85 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.687 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.83 HG23 ' HA ' ' A' ' 40' ' ' TYR . 1.6 p -80.41 140.79 35.84 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.3 p -52.68 97.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 122.06 0.933 . . . . 0.0 110.312 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -48.72 -176.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.768 -1.56 . . . . 0.0 112.744 -178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 2.6 pt-20 -96.0 161.96 13.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.754 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.19 144.28 36.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -104.53 145.72 29.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.787 0.327 . . . . 0.0 110.781 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -93.47 -45.42 7.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -147.42 97.38 2.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.852 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.34 -41.68 0.13 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.302 0.881 . . . . 0.0 115.302 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' TRP . 4.4 p-90 -79.31 113.13 17.2 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.983 0.892 . . . . 0.0 112.08 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.548 ' HB3' ' CG ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -116.97 126.18 52.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.661 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' MET . 0.0 OUTLIER -104.74 150.03 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -149.39 171.82 29.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.107 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.634 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.6 m -131.77 156.92 45.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.394 0.616 . . . . 0.0 112.276 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.83 ' HA ' HG23 ' A' ' 26' ' ' THR . 1.2 m-85 -136.68 144.84 44.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.46 86.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.889 0.376 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.18 -13.77 5.97 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.138 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.733 ' C ' HD12 ' A' ' 44' ' ' ILE . 5.4 pt20 -168.88 152.4 5.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.072 0.436 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -125.19 158.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 177.01 -144.47 6.81 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.618 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.966 ' O ' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -98.76 138.1 36.4 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 110.773 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -54.29 138.5 58.0 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HB2' HD11 ' A' ' 19' ' ' LEU . 60.9 Cg_endo -99.86 28.96 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.976 3.118 . . . . 0.0 111.821 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -30.9 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 2.5 m120 -41.4 -32.43 0.32 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 69.0 m-85 -158.31 64.62 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 0.0 110.018 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.77 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.05 163.54 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 10.8 tp -129.23 117.19 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.958 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.1 131.47 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.715 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 2' ' ' PRO . 1.4 mt-10 -102.25 121.13 41.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.373 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.62 83.7 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.954 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.666 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.519 0.199 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.35 -166.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.682 2.255 . . . . 0.0 112.264 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.29 163.87 18.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.122 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -113.68 116.13 28.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.716 0.293 . . . . 0.0 111.086 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.681 HG11 ' H ' ' A' ' 20' ' ' VAL . 14.9 t -87.68 145.38 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.7 -81.46 0.54 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.858 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.74 154.68 19.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.864 0.364 . . . . 0.0 111.427 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.683 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -115.11 145.55 42.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.862 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 5.3 t80 -135.6 139.45 43.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.494 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 7.6 m -88.75 108.48 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 169.26 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.244 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -127.74 116.73 20.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 110.511 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.05 153.44 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.862 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.51 106.32 0.28 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 11.8 t70 118.45 -28.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.481 0.712 . . . . 0.0 110.624 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 13' ' ' ARG . 12.8 pt-20 -106.04 150.04 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.207 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -127.01 121.03 30.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 11.3 p -80.41 147.07 31.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.769 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -95.56 151.13 19.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 0.0 111.479 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.683 ' C ' ' HB2' ' A' ' 8' ' ' ALA . 2.3 t -91.52 164.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.704 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.2 -39.01 41.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.422 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.79 33.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.81 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.632 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -102.59 165.87 10.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.804 0.335 . . . . 0.0 110.804 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.12 148.61 23.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 40' ' ' TYR . 3.9 t -120.21 164.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.254 0.549 . . . . 0.0 112.072 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 25' ' ' VAL . 3.4 p -81.68 140.73 34.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.6 p -53.45 91.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 122.094 0.95 . . . . 0.0 110.577 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.531 ' CB ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -47.3 -175.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.659 -1.61 . . . . 0.0 113.458 -178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 11.5 pt-20 -95.75 161.3 14.08 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.088 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -109.05 96.15 6.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 p -97.41 158.13 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.128 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -90.44 -6.33 55.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.404 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -104.26 175.45 5.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.011 0.434 . . . . 0.0 111.044 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.0 74.28 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 35' ' ' TRP . 42.6 p-90 -79.99 98.94 7.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.364 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -89.96 125.07 35.24 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -96.25 150.19 20.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 28' ' ' MET . . . -165.88 -176.46 37.25 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.94 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -134.94 142.5 46.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.845 0.322 . . . . 0.0 111.06 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -137.37 144.4 42.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.55 90.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.45 -27.46 2.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.093 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.705 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.1 pt20 -169.72 154.51 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -120.83 158.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.463 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 155.13 -128.3 2.27 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 17' ' ' LEU . 25.5 m-90 -99.02 140.44 33.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.842 ' O ' HD22 ' A' ' 17' ' ' LEU . 49.5 p90 -91.77 141.9 26.08 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.802 ' HA ' HD13 ' A' ' 17' ' ' LEU . 41.6 Cg_endo -92.0 58.83 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.512 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.429 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -49.81 -19.57 0.68 Allowed 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -42.86 -27.88 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.663 0.268 . . . . 0.0 111.662 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -154.42 64.98 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.09 163.36 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -113.43 116.97 30.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.39 136.17 46.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 1' ' ' ILE . 1.6 mt-10 -118.12 116.0 25.96 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.22 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.91 74.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 111.324 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.836 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.672 0.273 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.53 -165.9 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.555 2.17 . . . . 0.0 111.983 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.733 ' HB2' HG12 ' A' ' 27' ' ' VAL . . . -111.1 164.21 13.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.394 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 28.7 t80 -112.27 116.56 30.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' HG23 ' A' ' 25' ' ' VAL . 24.3 t -83.31 142.61 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -108.95 -68.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 156.97 17.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.484 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.557 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -113.96 138.77 49.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.331 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.801 ' HB2' HD12 ' A' ' 19' ' ' LEU . 8.0 t80 -135.44 130.05 34.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.567 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 10' ' ' VAL . 5.7 m -101.01 108.32 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.254 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 16' ' ' GLU . . . 179.67 114.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.07 117.08 27.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.272 0.558 . . . . 0.0 111.131 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.599 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.27 158.46 37.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.228 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.599 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -54.1 106.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.0 t0 95.64 9.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.934 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.31 137.52 52.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -129.91 150.89 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.79 135.12 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.98 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 9' ' ' TYR . 2.7 mt -95.36 150.75 19.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.004 0.43 . . . . 0.0 111.676 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.794 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.8 t -88.93 164.58 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.92 -35.43 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.027 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.31 67.92 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.605 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.794 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.13 -170.22 2.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.723 0.297 . . . . 0.0 110.713 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -120.53 140.75 51.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.147 0.499 . . . . 0.0 111.455 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 40' ' ' TYR . 25.4 t -136.18 158.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 30.3 p -97.13 95.5 7.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.569 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 47' ' ' PHE . 10.1 p -104.87 101.99 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.007 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.87 101.33 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.226 0.536 . . . . 0.0 111.635 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 29.1 tp10 -140.78 161.48 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.303 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 4.0 mttm -133.48 95.23 3.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.152 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.7 t -108.02 157.99 17.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.19 -6.6 59.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.804 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.99 173.19 6.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.99 76.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.997 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -80.06 127.9 32.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.4 . . . . 0.0 110.978 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 m0 -109.85 149.6 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.375 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -92.68 151.06 20.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.46 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -145.62 157.56 27.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.595 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 44' ' ' ILE . 13.9 m -121.14 152.47 38.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.3 137.04 40.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.86 86.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.49 -15.58 5.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.006 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.781 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -169.03 157.78 8.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.39 . . . . 0.0 110.375 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -133.85 158.24 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.172 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 169.16 -112.2 0.46 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.815 ' O ' HD22 ' A' ' 17' ' ' LEU . 4.4 t90 -98.78 145.43 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.342 . . . . 0.0 111.105 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.77 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -64.54 128.91 93.93 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.479 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.83 ' HA ' HD21 ' A' ' 17' ' ' LEU . 68.2 Cg_endo -89.16 12.99 2.55 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.902 2.401 . . . . 0.0 113.115 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.825 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -45.02 -16.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 2.8 m120 -41.53 -33.38 0.44 Allowed 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.106 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 65.6 m-85 -158.62 64.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.111 0.481 . . . . 0.0 109.817 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.34 163.52 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.147 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 42.9 tp -101.99 117.62 35.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.303 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.93 136.61 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.216 0.532 . . . . 0.0 112.287 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.06 115.87 19.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.066 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -83.87 78.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.233 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.4 t0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.865 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . 0.608 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -85.99 -166.23 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.737 2.291 . . . . 0.0 112.54 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -129.4 156.76 43.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -107.77 116.03 31.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.383 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 45.8 t -82.09 149.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.459 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -106.18 -42.2 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 156.88 36.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -109.05 143.33 38.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -128.48 120.27 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.222 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.8 m -88.63 108.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 161.68 110.42 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.061 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -123.08 113.9 19.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.408 0.623 . . . . 0.0 110.105 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -159.46 155.07 25.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.541 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 1.0 OUTLIER -63.12 105.43 0.7 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.488 178.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 13.7 t0 134.6 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.098 0.559 . . . . 0.0 111.585 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -97.52 150.3 21.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.444 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 47' ' ' PHE . 2.0 pp -111.62 120.84 43.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.314 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.545 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.6 p -85.7 147.18 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 17' ' ' LEU . 10.8 mt -126.4 151.3 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.961 0.41 . . . . 0.0 111.641 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.4 t -96.0 162.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.648 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -81.0 -33.06 33.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.487 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.44 63.76 0.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.819 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.681 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -140.32 -178.23 5.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.666 0.27 . . . . 0.0 110.553 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -120.27 126.59 50.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.347 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.704 HG22 ' CE2' ' A' ' 40' ' ' TYR . 45.5 t -111.53 162.01 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.102 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 0.6 OUTLIER -105.71 95.89 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.487 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.2 p -104.92 113.45 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.89 100.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 112.471 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 40.6 tp10 -140.95 161.56 37.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.189 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.61 94.95 2.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.665 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.37 157.45 18.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.374 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.4 t -93.27 -46.68 7.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.331 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.4 97.59 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.453 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 159.33 -147.04 13.84 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.134 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -79.75 134.03 36.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.395 -0.903 . . . . 0.0 112.844 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -96.42 131.14 43.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.18 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -99.49 151.09 21.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.135 0.493 . . . . 0.0 111.613 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.73 165.28 26.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.718 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -116.86 156.82 26.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.69 0.281 . . . . 0.0 110.433 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CE2' HG22 ' A' ' 25' ' ' VAL . 7.7 t80 -149.16 144.99 26.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 1.4 p30 -59.75 86.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.58 -34.46 1.8 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.93 168.55 8.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.841 0.353 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -110.71 152.68 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -166.74 -124.28 0.7 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.248 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.527 ' CZ2' ' HB2' ' A' ' 35' ' ' TRP . 1.6 t-105 -99.2 145.5 27.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 110.678 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.907 ' O ' HD22 ' A' ' 17' ' ' LEU . 3.6 p90 -58.51 112.21 4.64 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.155 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.826 ' HA ' HD13 ' A' ' 17' ' ' LEU . 91.9 Cg_endo -88.16 16.58 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.736 2.29 . . . . 0.0 112.598 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -56.47 -6.8 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.477 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.656 ' OD1' HD21 ' A' ' 17' ' ' LEU . 1.7 m120 -42.45 -30.88 0.37 Allowed 'General case' 0 C--N 1.342 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 66.6 m-85 -156.81 64.29 0.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.782 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.8 OUTLIER -139.48 163.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.659 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -104.5 117.52 34.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.24 137.01 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.38 116.05 26.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.308 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.6 73.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.945 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.678 0.275 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.538 ' HG2' ' HD2' ' A' ' 24' ' ' ARG . 97.8 Cg_endo -84.98 -164.66 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.72 2.28 . . . . 0.0 112.766 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -121.89 152.75 39.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -107.88 120.6 42.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.277 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 25' ' ' VAL . 75.1 t -77.56 151.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 111.692 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.15 151.22 45.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -91.16 139.62 30.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.895 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -135.14 148.18 49.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 m -87.86 128.26 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -119.73 -169.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 73.4 mt-10 -81.89 176.76 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.713 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.8 -154.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.668 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 5.6 mm-40 -50.46 105.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 122.124 0.964 . . . . 0.0 110.682 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 21.2 t0 154.76 -54.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.229 -1.805 . . . . 0.0 107.533 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.721 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.53 150.43 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.943 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.95 HD23 ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -121.53 150.65 41.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 p -70.69 150.13 46.27 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.499 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.755 HD22 ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.69 150.72 20.17 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.207 0.527 . . . . 0.0 111.389 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 23' ' ' SER . 3.3 t -69.15 161.08 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.142 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.918 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -95.7 -39.21 10.0 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.162 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 62.75 0.3 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.753 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.73 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -149.19 176.0 10.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.731 0.3 . . . . 0.0 110.703 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 2' ' ' PRO . 4.4 mmt85 -98.13 148.31 23.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.507 . . . . 0.0 111.54 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 5' ' ' VAL . 18.9 t -126.73 166.45 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 39' ' ' SER . 7.0 p -80.39 139.46 36.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 54' ' ' GLU . 7.2 p -54.12 128.05 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.517 0.675 . . . . 0.0 111.362 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.415 ' HE3' ' HB3' ' A' ' 28' ' ' MET . 45.6 mmm -64.35 -176.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.997 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -105.53 159.91 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.671 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -86.08 96.54 9.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -106.74 157.87 17.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.356 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 t -85.79 -27.67 25.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.62 164.65 12.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -19.83 44.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.654 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -80.02 91.84 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -90.03 128.66 36.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.09 149.84 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -168.93 176.74 43.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.554 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.4 OUTLIER -124.88 156.5 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.264 0.554 . . . . 0.0 111.493 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -149.25 145.57 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.91 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.35 86.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.471 . . . . 0.0 110.613 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.74 -39.25 0.74 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -169.84 177.45 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.897 0.38 . . . . 0.0 111.223 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.4 mp -124.59 156.94 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.829 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 17' ' ' LEU . . . 162.76 -153.86 24.6 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.078 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.523 ' N ' HD21 ' A' ' 17' ' ' LEU . 6.1 m-90 -99.37 130.21 45.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.761 0.315 . . . . 0.0 111.07 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.95 ' CE1' HD23 ' A' ' 17' ' ' LEU . 84.2 m-85 -124.53 132.33 24.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.755 ' HD2' HD22 ' A' ' 19' ' ' LEU . 9.3 Cg_exo -71.17 105.81 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.548 2.165 . . . . 0.0 112.909 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.461 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 t -60.23 -7.87 2.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.2 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.45 -28.42 0.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.475 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -147.76 63.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.414 178.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.2 m -139.36 152.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.145 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 8.6 tp -115.41 116.79 28.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -106.35 136.92 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.81 117.22 30.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.005 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.54 84.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.242 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 t0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.974 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.62 0.248 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.59 -176.0 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.72 2.28 . . . . 0.0 112.047 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -111.31 153.51 25.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.549 ' HD2' HD23 ' A' ' 53' ' ' LEU . 1.2 m-30 -108.1 116.37 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 23' ' ' SER . 43.6 t -82.4 142.01 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.819 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -92.23 -96.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.103 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.15 148.69 24.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.174 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -86.45 141.01 29.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.449 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 27.6 t80 -135.44 139.45 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.624 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.4 m -88.65 113.15 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.327 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.5 117.87 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 111.338 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.709 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.13 173.49 16.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.382 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.709 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -53.5 107.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.473 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER 85.16 15.76 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -127.23 144.0 51.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -128.89 151.35 49.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.352 0.596 . . . . 0.0 111.877 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 p -88.3 148.22 24.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 48' ' ' PRO . 1.8 mt -94.19 150.68 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.367 0.604 . . . . 0.0 111.563 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -97.26 165.29 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.571 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.594 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -103.46 100.78 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.318 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.23 15.15 78.82 Favored Glycine 0 C--N 1.319 -0.382 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.632 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -86.54 176.43 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.048 0.424 . . . . 0.0 110.827 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mmt-85 -120.82 148.61 43.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 111.658 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 39' ' ' SER . 4.7 t -124.92 165.27 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.052 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 25' ' ' VAL . 2.6 p -81.68 139.57 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.0 p -54.13 101.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 0.0 110.613 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.416 ' HG2' ' HB3' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -49.03 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.588 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.7 pt-20 -95.05 134.56 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.733 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -66.21 96.98 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.957 0.408 . . . . 0.0 110.489 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.8 149.24 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.721 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -93.34 -29.05 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.127 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.67 170.3 9.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.17 -22.2 9.55 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.987 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -79.75 133.19 36.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.585 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -134.36 125.35 27.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.037 0.446 . . . . 0.0 111.621 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -106.56 150.38 26.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.796 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.14 -169.96 33.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.945 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.561 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -129.36 156.75 43.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.31 0.576 . . . . 0.0 111.588 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' A' ' 25' ' ' VAL . 77.2 t80 -139.38 145.55 39.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.918 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -59.56 86.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 110.62 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 148.04 -32.26 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.395 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -169.92 170.86 7.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 111.429 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.5 mp -119.04 158.34 20.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 160.01 -125.53 1.49 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.196 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.644 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -98.55 146.87 25.35 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 120.504 0.193 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -73.75 144.2 82.67 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.937 0.398 . . . . 0.0 111.807 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' O ' HG13 ' A' ' 52' ' ' VAL . 86.1 Cg_endo -94.64 33.99 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.262 2.642 . . . . 0.0 112.145 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -34.45 -28.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 m-20 -41.66 -28.96 0.16 Allowed 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -160.58 64.89 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 110.206 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.63 163.34 28.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.397 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 4' ' ' PHE . 8.5 tp -128.65 117.28 20.93 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.917 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -106.08 134.98 48.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.39 . . . . 0.0 111.792 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' ' CE2' ' A' ' 4' ' ' PHE . 1.7 mt-10 -103.27 115.97 31.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.75 85.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.274 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.55 0.214 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.17 -175.66 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.878 2.385 . . . . 0.0 112.572 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -97.51 171.34 8.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.192 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.662 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.9 t80 -127.38 119.22 25.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.945 0.403 . . . . 0.0 111.537 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 25' ' ' VAL . 37.2 t -73.9 135.98 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.849 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -83.3 -72.2 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.55 150.11 35.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.56 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.83 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -88.21 132.11 34.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.003 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 55.5 t80 -134.74 148.01 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.07 141.35 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 16' ' ' GLU . . . -138.79 -167.89 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -81.47 176.98 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.822 -179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.69 -154.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.084 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 15.4 mm-40 -50.29 105.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 122.127 0.965 . . . . 0.0 110.659 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 4.0 t70 152.45 -55.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.282 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -128.62 149.96 50.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.805 177.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -129.59 150.74 50.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 p -66.16 149.89 49.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.956 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 47' ' ' PHE . 2.4 mt -93.3 150.8 20.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.214 0.53 . . . . 0.0 111.309 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.844 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.5 t -76.08 161.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.995 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.83 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 mttt -90.18 -42.43 11.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.166 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.25 62.52 0.28 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.898 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.844 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -136.06 -170.07 2.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.625 -0.288 . . . . 0.0 110.651 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -120.43 132.26 55.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.264 0.554 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 5' ' ' VAL . 21.4 t -110.56 166.57 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.566 HG21 ' HB2' ' A' ' 39' ' ' SER . 11.6 p -80.27 139.21 36.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.736 0.303 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.634 HG23 ' CG ' ' A' ' 54' ' ' GLU . 11.0 p -54.27 122.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.571 0.7 . . . . 0.0 111.436 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.426 ' HE1' ' H ' ' A' ' 47' ' ' PHE . 75.7 mmm -54.12 -176.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.0 pt-20 -111.24 140.12 46.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -69.64 96.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.53 154.12 21.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.327 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.0 t -93.36 -29.61 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.0 167.86 12.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.932 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.24 -16.3 53.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.97 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.47 96.15 7.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CE3' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -89.98 125.56 35.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.095 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.65 149.73 21.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.53 -173.19 35.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.566 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.3 OUTLIER -135.11 144.27 47.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.156 0.503 . . . . 0.0 111.282 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -140.87 145.55 36.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.082 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.51 86.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.142 0.496 . . . . 0.0 110.371 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 156.15 -40.77 0.58 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.066 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -169.98 162.16 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.7 mp -110.98 156.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 153.98 -137.56 5.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.617 ' O ' HD21 ' A' ' 17' ' ' LEU . 31.4 m-90 -99.26 145.42 27.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' HD22 ' A' ' 19' ' ' LEU . 1.2 t80 -141.59 119.92 7.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 19' ' ' LEU . 84.9 Cg_exo -50.6 88.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.832 2.355 . . . . 0.0 113.136 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.504 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -60.23 -12.24 8.34 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.205 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.75 -23.89 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.189 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -145.57 63.87 1.26 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.438 0.637 . . . . 0.0 110.571 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.504 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.5 m -138.71 151.18 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.214 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.662 HD23 ' CD2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -106.57 117.68 34.67 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.634 ' CG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -105.31 133.92 49.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.477 . . . . 0.0 111.872 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -120.34 117.32 27.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.371 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.73 82.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 0.0 111.196 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.865 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . 0.794 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.624 0.25 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.52 -165.91 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.604 2.203 . . . . 0.0 112.143 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.34 159.04 28.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.45 117.48 32.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.595 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 20' ' ' VAL . 21.2 t -87.24 148.71 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -106.0 -75.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.14 156.92 16.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.783 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . . . -105.58 147.45 28.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.551 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.425 ' N ' ' HB2' ' A' ' 19' ' ' LEU . 6.4 t80 -135.5 135.85 40.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.9 m -88.89 108.23 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.266 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 162.14 88.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 116.59 20.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.137 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.17 149.46 22.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.354 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 pt-20 -54.16 106.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 36.2 t70 124.69 -31.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.932 0.77 . . . . 0.0 110.364 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 9.5 pt-20 -108.34 149.94 28.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.614 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.927 HD23 ' CE3' ' A' ' 46' ' ' TRP . 3.2 pp -107.56 131.94 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.703 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 54.4 p -106.7 146.96 30.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.535 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 50' ' ' ASN . 3.0 mm? -95.38 149.68 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.309 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' H ' HG11 ' A' ' 5' ' ' VAL . 2.0 t -94.85 164.68 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.215 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.783 ' HA ' ' HB2' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -73.3 -52.12 15.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.31 27.35 0.12 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.779 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.408 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -95.74 171.38 8.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -101.31 148.71 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 40' ' ' TYR . 25.9 t -124.94 165.26 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.533 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.4 p -81.24 139.01 35.73 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.4 p -54.84 118.48 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.369 0.604 . . . . 0.0 111.216 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.471 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -60.55 -175.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.17 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -95.51 161.88 13.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.138 -179.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -126.35 99.47 5.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.861 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.26 157.97 17.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -59.89 -26.39 65.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.932 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.84 169.15 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.931 0.396 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 36' ' ' TRP . . . -74.18 -7.63 77.54 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.255 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -86.49 133.16 33.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.992 0.396 . . . . 0.0 110.925 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 10.6 m-90 -141.12 126.13 18.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.37 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.4 149.05 24.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.076 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -134.07 158.43 23.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.852 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -111.07 153.35 25.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CE2' HG22 ' A' ' 25' ' ' VAL . 8.1 m-85 -122.8 145.03 48.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.94 86.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.21 -15.32 7.3 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.568 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.764 ' C ' HD12 ' A' ' 44' ' ' ILE . 7.0 pt20 -159.25 174.83 14.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.292 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.764 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -136.96 156.83 35.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . -176.05 -146.18 5.85 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CE3' HD23 ' A' ' 17' ' ' LEU . 2.1 t90 -99.3 146.36 26.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.961 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.901 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -55.73 113.24 5.32 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 17' ' ' LEU . 74.0 Cg_endo -94.49 37.04 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.091 2.527 . . . . 0.0 111.637 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.587 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -53.55 -9.6 0.21 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 19' ' ' LEU . 3.3 m-20 -42.35 -30.43 0.33 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 91.3 m-85 -157.81 64.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.209 0.528 . . . . 0.0 109.745 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -139.01 163.46 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.476 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 18.2 tp -114.46 116.92 29.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.705 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.62 ' OE1' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -106.54 137.03 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.912 0.387 . . . . 0.0 112.009 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.794 ' O ' HD13 ' A' ' 1' ' ' ILE . 0.6 OUTLIER -117.26 115.83 26.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG23 ' OE1' ' A' ' 54' ' ' GLU . 56.6 t -96.43 80.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.181 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.88 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.557 0.218 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.95 -170.75 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -98.0 170.93 8.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 53' ' ' LEU . 76.2 t80 -131.35 130.05 42.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.912 0.387 . . . . 0.0 111.729 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 19' ' ' LEU . 35.1 t -85.12 135.74 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -86.79 -47.85 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.504 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.01 150.63 44.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -82.33 139.88 33.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . 6.6 t80 -135.67 125.09 24.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.1 m -88.79 108.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.776 ' HB1' ' OE2' ' A' ' 16' ' ' GLU . . . -178.57 104.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.3 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.49 117.58 22.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.289 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.737 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.3 175.24 14.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.392 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.737 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 19.3 pt-20 -53.62 108.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.384 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER 87.13 10.96 0.14 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.776 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -127.25 137.75 52.94 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.998 0.428 . . . . 0.0 110.721 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.73 143.42 50.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -76.86 147.33 37.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD21 ' CB ' ' A' ' 48' ' ' PRO . 3.8 mm? -95.24 150.5 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.127 0.489 . . . . 0.0 111.61 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 23' ' ' SER . 0.9 OUTLIER -91.73 152.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.732 ' HE2' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.22 -42.4 95.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.87 24.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.267 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.782 ' HB2' HG11 ' A' ' 20' ' ' VAL . 13.8 t -78.12 -171.63 2.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.101 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -118.85 148.65 42.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.058 0.456 . . . . 0.0 111.235 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG13 ' CG ' ' A' ' 40' ' ' TYR . 42.6 t -121.44 165.52 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.586 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.561 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -80.93 139.95 35.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.7 p -53.68 90.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 110.55 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.6 mpp? -57.8 -175.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.688 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HB2' ' CD1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -95.93 161.19 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.011 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -135.29 96.69 3.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.947 0.403 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' CE2' ' A' ' 36' ' ' TRP . 25.0 t -107.14 157.68 17.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.178 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -56.57 -43.96 80.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.8 167.87 20.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.45 -21.02 63.01 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.966 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -82.12 104.59 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.595 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -160.98 133.94 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 3.9 mtt180 -111.34 130.04 55.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CG ' ' A' ' 28' ' ' MET . . . -102.73 -160.61 25.79 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.555 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -134.63 152.74 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.455 0.645 . . . . 0.0 111.947 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.689 ' CE1' HD22 ' A' ' 17' ' ' LEU . 14.3 m-85 -132.0 144.84 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.813 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -60.9 86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.69 -20.36 4.36 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.711 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.8 pt20 -169.68 165.86 9.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -117.54 159.41 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.074 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.449 ' HA2' ' NE ' ' A' ' 37' ' ' ARG . . . -175.47 -151.67 8.81 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.385 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' O ' HD21 ' A' ' 17' ' ' LEU . 69.0 t90 -97.36 130.08 44.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.2 114.29 10.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.698 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.907 ' CB ' HD21 ' A' ' 19' ' ' LEU . 81.6 Cg_endo -90.16 49.1 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.999 2.466 . . . . 0.0 111.711 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.544 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -37.05 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.9 m120 -42.37 -28.31 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.727 0.299 . . . . 0.0 111.418 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 61.4 m-85 -156.75 64.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.161 0.505 . . . . 0.0 109.944 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -138.91 163.32 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.648 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -126.53 116.78 21.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 56' ' ' VAL . 1.5 tt0 -106.45 127.06 53.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.871 0.367 . . . . 0.0 111.712 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.64 116.01 30.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.504 HG22 ' OE2' ' A' ' 54' ' ' GLU . 21.4 t -80.17 80.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.843 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.542 0.211 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.35 -167.43 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.715 2.277 . . . . 0.0 112.287 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -120.42 157.79 28.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 6.3 m-85 -109.81 116.29 31.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 20' ' ' VAL . 38.6 t -84.46 152.16 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.692 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 14.2 mtpt -111.53 -48.77 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 157.07 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.63 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.23 143.96 29.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.625 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 t80 -135.72 135.88 40.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.0 m -88.66 108.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.306 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.82 107.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.39 117.15 21.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 111.151 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.35 159.74 39.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.151 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.643 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 9.9 pt-20 -54.06 106.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.9 t0 97.47 0.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.961 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.35 129.46 47.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.7 pt? -127.51 142.7 51.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -72.21 147.16 46.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.944 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.625 HD12 ' HB2' ' A' ' 9' ' ' TYR . 5.0 mt -95.29 151.02 19.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.0 111.688 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.72 165.2 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.188 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.7 105.15 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.775 0.797 . . . . 0.0 111.295 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.57 18.58 73.9 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.375 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -97.91 -178.45 4.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -120.37 148.4 43.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.15 0.5 . . . . 0.0 111.25 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 40' ' ' TYR . 4.0 t -120.83 166.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.832 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 5.5 p -80.27 139.49 36.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.9 p -54.14 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.802 0.81 . . . . 0.0 111.651 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.493 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -51.93 -175.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.851 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.94 152.39 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.271 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.79 96.5 10.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.694 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 36' ' ' TRP . 13.0 t -99.42 143.16 29.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.827 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 -44.79 8.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.527 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -146.58 106.16 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.686 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.45 -134.55 5.22 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.841 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -104.53 133.95 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.817 0.341 . . . . 0.0 110.609 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -88.61 125.25 34.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 111.204 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -93.66 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.69 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -168.83 167.63 40.54 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.071 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.623 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.8 m -125.33 156.38 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 111.448 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.548 ' HB2' HG13 ' A' ' 25' ' ' VAL . 24.1 t80 -149.07 144.94 27.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.227 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.06 86.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.81 -27.43 1.46 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.395 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 44' ' ' ILE . 6.9 pt20 -169.74 167.52 9.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 111.58 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.1 mp -136.14 156.74 37.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.939 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 147.38 -100.39 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.561 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -99.21 146.29 26.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.48 148.67 74.03 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 52' ' ' VAL . 89.7 Cg_endo -93.12 32.21 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.062 2.508 . . . . 0.0 111.888 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -39.33 -21.63 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.511 ' CB ' HD11 ' A' ' 19' ' ' LEU . 1.7 m120 -41.31 -31.07 0.2 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 63.8 m-85 -160.69 64.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.864 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.77 163.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.223 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -124.2 117.84 25.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.734 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.4 129.87 53.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 0.0 111.768 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.53 138.17 32.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.748 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.88 75.81 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.267 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.878 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.537 0.208 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 92.8 Cg_endo -86.05 -167.13 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.602 2.201 . . . . 0.0 112.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -112.7 155.39 24.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 m-85 -109.2 116.38 31.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.673 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 23' ' ' SER . 59.9 t -77.63 158.62 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.687 0.28 . . . . 0.0 110.752 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 5' ' ' VAL . 13.4 mtpt -114.54 -69.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.806 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.2 157.05 25.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.75 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -96.98 138.87 33.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.201 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 19' ' ' LEU . 3.1 t80 -136.0 131.68 35.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 10' ' ' VAL . 3.2 m -88.72 108.54 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 95.49 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.16 117.02 28.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.282 0.563 . . . . 0.0 110.921 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.17 156.65 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.173 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 6.8 pt-20 -54.04 106.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.7 t70 105.15 -17.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.922 0.764 . . . . 0.0 110.963 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -114.14 141.33 47.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.966 HD21 ' O ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -129.44 149.36 51.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.03 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 p -77.68 148.11 35.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 48' ' ' PRO . 3.5 mm? -94.42 148.96 21.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.04 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 23' ' ' SER . 1.9 t -95.81 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.323 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -67.23 -36.12 81.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.189 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.02 32.09 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.265 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -79.09 -176.93 5.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.322 . . . . 0.0 110.894 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' NE ' ' CZ ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -120.45 148.73 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' CD2' ' A' ' 40' ' ' TYR . 40.6 t -119.89 165.85 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.687 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.83 HG23 ' HA ' ' A' ' 40' ' ' TYR . 1.6 p -80.41 140.79 35.84 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.3 p -52.68 97.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 122.06 0.933 . . . . 0.0 110.312 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -48.72 -176.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.768 -1.56 . . . . 0.0 112.744 -178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 2.6 pt-20 -96.0 161.96 13.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.754 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.19 144.28 36.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -104.53 145.72 29.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.787 0.327 . . . . 0.0 110.781 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -93.47 -45.42 7.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -147.42 97.38 2.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.852 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.34 -41.68 0.13 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.302 0.881 . . . . 0.0 115.302 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' TRP . 4.4 p-90 -79.31 113.13 17.2 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.983 0.892 . . . . 0.0 112.08 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.548 ' HB3' ' CG ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -116.97 126.18 52.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.661 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' MET . 0.0 OUTLIER -104.74 150.03 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -149.39 171.82 29.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.107 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.634 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.6 m -131.77 156.92 45.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.394 0.616 . . . . 0.0 112.276 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.83 ' HA ' HG23 ' A' ' 26' ' ' THR . 1.2 m-85 -136.68 144.84 44.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -61.46 86.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.889 0.376 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.18 -13.77 5.97 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.138 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.733 ' C ' HD12 ' A' ' 44' ' ' ILE . 5.4 pt20 -168.88 152.4 5.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.072 0.436 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -125.19 158.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 177.01 -144.47 6.81 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.618 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.966 ' O ' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -98.76 138.1 36.4 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 110.773 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -54.29 138.5 58.0 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HB2' HD11 ' A' ' 19' ' ' LEU . 60.9 Cg_endo -99.86 28.96 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.976 3.118 . . . . 0.0 111.821 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -30.9 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 2.5 m120 -41.4 -32.43 0.32 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 69.0 m-85 -158.31 64.62 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 0.0 110.018 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.77 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.05 163.54 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.619 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 10.8 tp -129.23 117.19 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.958 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.1 131.47 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.715 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 2' ' ' PRO . 1.4 mt-10 -102.25 121.13 41.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.373 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.62 83.7 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.954 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . 0.666 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.519 0.199 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.35 -166.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.682 2.255 . . . . 0.0 112.264 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.29 163.87 18.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.122 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -113.68 116.13 28.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.716 0.293 . . . . 0.0 111.086 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.681 HG11 ' H ' ' A' ' 20' ' ' VAL . 14.9 t -87.68 145.38 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.7 -81.46 0.54 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.858 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.74 154.68 19.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.864 0.364 . . . . 0.0 111.427 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.683 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -115.11 145.55 42.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.862 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 5.3 t80 -135.6 139.45 43.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.494 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 7.6 m -88.75 108.48 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 169.26 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.244 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -127.74 116.73 20.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 110.511 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.05 153.44 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.862 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.51 106.32 0.28 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 11.8 t70 118.45 -28.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.481 0.712 . . . . 0.0 110.624 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 13' ' ' ARG . 12.8 pt-20 -106.04 150.04 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.207 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -127.01 121.03 30.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 11.3 p -80.41 147.07 31.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.769 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -95.56 151.13 19.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 0.0 111.479 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.683 ' C ' ' HB2' ' A' ' 8' ' ' ALA . 2.3 t -91.52 164.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.704 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.2 -39.01 41.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.422 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.79 33.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.81 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.632 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -102.59 165.87 10.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.804 0.335 . . . . 0.0 110.804 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.12 148.61 23.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 40' ' ' TYR . 3.9 t -120.21 164.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.254 0.549 . . . . 0.0 112.072 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 25' ' ' VAL . 3.4 p -81.68 140.73 34.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.6 p -53.45 91.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 122.094 0.95 . . . . 0.0 110.577 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.531 ' CB ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -47.3 -175.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.659 -1.61 . . . . 0.0 113.458 -178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 11.5 pt-20 -95.75 161.3 14.08 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.088 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -109.05 96.15 6.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 p -97.41 158.13 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.128 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -90.44 -6.33 55.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.404 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -104.26 175.45 5.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.011 0.434 . . . . 0.0 111.044 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.0 74.28 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 35' ' ' TRP . 42.6 p-90 -79.99 98.94 7.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.364 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -89.96 125.07 35.24 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -96.25 150.19 20.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 28' ' ' MET . . . -165.88 -176.46 37.25 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.94 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -134.94 142.5 46.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.845 0.322 . . . . 0.0 111.06 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.593 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -137.37 144.4 42.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.55 90.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.45 -27.46 2.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.093 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.705 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.1 pt20 -169.72 154.51 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -120.83 158.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.463 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 155.13 -128.3 2.27 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 17' ' ' LEU . 25.5 m-90 -99.02 140.44 33.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.842 ' O ' HD22 ' A' ' 17' ' ' LEU . 49.5 p90 -91.77 141.9 26.08 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.802 ' HA ' HD13 ' A' ' 17' ' ' LEU . 41.6 Cg_endo -92.0 58.83 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.512 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.429 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -49.81 -19.57 0.68 Allowed 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -42.86 -27.88 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.663 0.268 . . . . 0.0 111.662 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -154.42 64.98 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.09 163.36 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -113.43 116.97 30.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.39 136.17 46.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 1' ' ' ILE . 1.6 mt-10 -118.12 116.0 25.96 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.22 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.91 74.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 111.324 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.836 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.672 0.273 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.53 -165.9 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.555 2.17 . . . . 0.0 111.983 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.733 ' HB2' HG12 ' A' ' 27' ' ' VAL . . . -111.1 164.21 13.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.394 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 28.7 t80 -112.27 116.56 30.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' HG23 ' A' ' 25' ' ' VAL . 24.3 t -83.31 142.61 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -108.95 -68.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.72 156.97 17.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.484 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.557 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -113.96 138.77 49.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.331 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.801 ' HB2' HD12 ' A' ' 19' ' ' LEU . 8.0 t80 -135.44 130.05 34.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.567 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 10' ' ' VAL . 5.7 m -101.01 108.32 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.254 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 16' ' ' GLU . . . 179.67 114.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.07 117.08 27.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.272 0.558 . . . . 0.0 111.131 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.599 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.27 158.46 37.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.228 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.599 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -54.1 106.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.0 t0 95.64 9.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.934 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.31 137.52 52.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -129.91 150.89 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.248 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.79 135.12 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.98 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 9' ' ' TYR . 2.7 mt -95.36 150.75 19.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.004 0.43 . . . . 0.0 111.676 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.794 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.8 t -88.93 164.58 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.92 -35.43 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.027 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.31 67.92 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.605 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.794 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.13 -170.22 2.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.723 0.297 . . . . 0.0 110.713 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -120.53 140.75 51.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.147 0.499 . . . . 0.0 111.455 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 40' ' ' TYR . 25.4 t -136.18 158.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 30.3 p -97.13 95.5 7.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.569 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' A' ' 47' ' ' PHE . 10.1 p -104.87 101.99 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.007 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.87 101.33 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.226 0.536 . . . . 0.0 111.635 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 29.1 tp10 -140.78 161.48 37.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.303 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 4.0 mttm -133.48 95.23 3.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.152 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.7 t -108.02 157.99 17.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.19 -6.6 59.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.804 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.99 173.19 6.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.99 76.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.997 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -80.06 127.9 32.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.4 . . . . 0.0 110.978 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 m0 -109.85 149.6 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.375 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -92.68 151.06 20.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.46 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -145.62 157.56 27.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.595 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 44' ' ' ILE . 13.9 m -121.14 152.47 38.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.3 137.04 40.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.86 86.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.49 -15.58 5.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.006 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.781 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -169.03 157.78 8.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.39 . . . . 0.0 110.375 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -133.85 158.24 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.172 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 169.16 -112.2 0.46 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.442 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.815 ' O ' HD22 ' A' ' 17' ' ' LEU . 4.4 t90 -98.78 145.43 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.342 . . . . 0.0 111.105 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.77 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -64.54 128.91 93.93 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.479 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.83 ' HA ' HD21 ' A' ' 17' ' ' LEU . 68.2 Cg_endo -89.16 12.99 2.55 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.902 2.401 . . . . 0.0 113.115 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.825 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -45.02 -16.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 2.8 m120 -41.53 -33.38 0.44 Allowed 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.106 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 65.6 m-85 -158.62 64.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.111 0.481 . . . . 0.0 109.817 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.34 163.52 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.147 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 42.9 tp -101.99 117.62 35.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.303 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.93 136.61 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.216 0.532 . . . . 0.0 112.287 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.06 115.87 19.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.066 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -83.87 78.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.233 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.4 t0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.865 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.608 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -85.99 -166.23 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.737 2.291 . . . . 0.0 112.54 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -129.4 156.76 43.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.731 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -107.77 116.03 31.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.383 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 45.8 t -82.09 149.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.459 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -106.18 -42.2 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 156.88 36.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.669 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -109.05 143.33 38.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -128.48 120.27 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.222 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.8 m -88.63 108.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 161.68 110.42 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.061 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -123.08 113.9 19.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.408 0.623 . . . . 0.0 110.105 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -159.46 155.07 25.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.541 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 1.0 OUTLIER -63.12 105.43 0.7 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.488 178.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 13.7 t0 134.6 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.098 0.559 . . . . 0.0 111.585 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -97.52 150.3 21.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.444 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 47' ' ' PHE . 2.0 pp -111.62 120.84 43.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.314 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.545 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.6 p -85.7 147.18 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 17' ' ' LEU . 10.8 mt -126.4 151.3 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.961 0.41 . . . . 0.0 111.641 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.4 t -96.0 162.24 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.648 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -81.0 -33.06 33.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.487 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.44 63.76 0.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.819 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.681 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -140.32 -178.23 5.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.666 0.27 . . . . 0.0 110.553 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -120.27 126.59 50.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.347 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.704 HG22 ' CE2' ' A' ' 40' ' ' TYR . 45.5 t -111.53 162.01 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.102 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 0.6 OUTLIER -105.71 95.89 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.487 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.2 p -104.92 113.45 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.89 100.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 112.471 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 40.6 tp10 -140.95 161.56 37.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.189 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.61 94.95 2.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.665 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.37 157.45 18.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.374 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.4 t -93.27 -46.68 7.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.331 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.4 97.59 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.453 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 159.33 -147.04 13.84 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.134 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -79.75 134.03 36.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.395 -0.903 . . . . 0.0 112.844 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -96.42 131.14 43.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.18 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -99.49 151.09 21.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.135 0.493 . . . . 0.0 111.613 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.73 165.28 26.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.718 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 0.4 OUTLIER -116.86 156.82 26.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.69 0.281 . . . . 0.0 110.433 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CE2' HG22 ' A' ' 25' ' ' VAL . 7.7 t80 -149.16 144.99 26.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 1.4 p30 -59.75 86.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.58 -34.46 1.8 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.93 168.55 8.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.841 0.353 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 39' ' ' SER . 1.7 mp -110.71 152.68 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -166.74 -124.28 0.7 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.248 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.527 ' CZ2' ' HB2' ' A' ' 35' ' ' TRP . 1.6 t-105 -99.2 145.5 27.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 110.678 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.907 ' O ' HD22 ' A' ' 17' ' ' LEU . 3.6 p90 -58.51 112.21 4.64 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.155 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.826 ' HA ' HD13 ' A' ' 17' ' ' LEU . 91.9 Cg_endo -88.16 16.58 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.736 2.29 . . . . 0.0 112.598 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -56.47 -6.8 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.477 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.656 ' OD1' HD21 ' A' ' 17' ' ' LEU . 1.7 m120 -42.45 -30.88 0.37 Allowed 'General case' 0 C--N 1.342 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 66.6 m-85 -156.81 64.29 0.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.782 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.8 OUTLIER -139.48 163.71 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.659 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -104.5 117.52 34.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.24 137.01 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.38 116.05 26.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.308 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.6 73.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.945 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.678 0.275 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.538 ' HG2' ' HD2' ' A' ' 24' ' ' ARG . 97.8 Cg_endo -84.98 -164.66 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.72 2.28 . . . . 0.0 112.766 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -121.89 152.75 39.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -107.88 120.6 42.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.277 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 25' ' ' VAL . 75.1 t -77.56 151.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -104.06 -46.16 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 111.692 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.15 151.22 45.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.674 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -91.16 139.62 30.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.895 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -135.14 148.18 49.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 m -87.86 128.26 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -119.73 -169.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 73.4 mt-10 -81.89 176.76 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.713 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.8 -154.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.668 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 5.6 mm-40 -50.46 105.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 122.124 0.964 . . . . 0.0 110.682 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 21.2 t0 154.76 -54.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.229 -1.805 . . . . 0.0 107.533 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.721 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.53 150.43 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.943 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.95 HD23 ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -121.53 150.65 41.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 p -70.69 150.13 46.27 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.499 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.755 HD22 ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.69 150.72 20.17 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.207 0.527 . . . . 0.0 111.389 -179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 23' ' ' SER . 3.3 t -69.15 161.08 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.142 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.918 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -95.7 -39.21 10.0 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.162 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 62.75 0.3 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.753 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.73 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -149.19 176.0 10.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.731 0.3 . . . . 0.0 110.703 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 2' ' ' PRO . 4.4 mmt85 -98.13 148.31 23.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.507 . . . . 0.0 111.54 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.557 HG23 HG23 ' A' ' 5' ' ' VAL . 18.9 t -126.73 166.45 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.279 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 39' ' ' SER . 7.0 p -80.39 139.46 36.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 54' ' ' GLU . 7.2 p -54.12 128.05 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.517 0.675 . . . . 0.0 111.362 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.415 ' HE3' ' HB3' ' A' ' 28' ' ' MET . 45.6 mmm -64.35 -176.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.997 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -105.53 159.91 15.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.671 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -86.08 96.54 9.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -106.74 157.87 17.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.356 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 t -85.79 -27.67 25.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.62 164.65 12.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -19.83 44.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.654 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -80.02 91.84 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -90.03 128.66 36.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.09 149.84 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -168.93 176.74 43.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.554 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.4 OUTLIER -124.88 156.5 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.264 0.554 . . . . 0.0 111.493 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -149.25 145.57 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.91 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.35 86.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.471 . . . . 0.0 110.613 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.74 -39.25 0.74 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -169.84 177.45 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.897 0.38 . . . . 0.0 111.223 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.4 mp -124.59 156.94 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.829 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 17' ' ' LEU . . . 162.76 -153.86 24.6 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.078 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.523 ' N ' HD21 ' A' ' 17' ' ' LEU . 6.1 m-90 -99.37 130.21 45.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.761 0.315 . . . . 0.0 111.07 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.95 ' CE1' HD23 ' A' ' 17' ' ' LEU . 84.2 m-85 -124.53 132.33 24.29 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.755 ' HD2' HD22 ' A' ' 19' ' ' LEU . 9.3 Cg_exo -71.17 105.81 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.548 2.165 . . . . 0.0 112.909 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.461 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 2.2 t -60.23 -7.87 2.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.2 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.45 -28.42 0.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.475 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -147.76 63.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.414 178.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.2 m -139.36 152.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.145 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 8.6 tp -115.41 116.79 28.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -106.35 136.92 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.81 117.22 30.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.005 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.54 84.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.242 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 t0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.974 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.62 0.248 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.59 -176.0 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.72 2.28 . . . . 0.0 112.047 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -111.31 153.51 25.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.549 ' HD2' HD23 ' A' ' 53' ' ' LEU . 1.2 m-30 -108.1 116.37 31.83 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 23' ' ' SER . 43.6 t -82.4 142.01 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.819 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -92.23 -96.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.103 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.15 148.69 24.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.174 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -86.45 141.01 29.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.449 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 27.6 t80 -135.44 139.45 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.624 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.4 m -88.65 113.15 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.59 96.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.327 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.5 117.87 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 111.338 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.709 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.13 173.49 16.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.382 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.709 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -53.5 107.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.473 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER 85.16 15.76 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' CB ' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -127.23 144.0 51.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -128.89 151.35 49.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.352 0.596 . . . . 0.0 111.877 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 p -88.3 148.22 24.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 48' ' ' PRO . 1.8 mt -94.19 150.68 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.367 0.604 . . . . 0.0 111.563 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -97.26 165.29 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.571 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.594 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -103.46 100.78 10.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.318 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.23 15.15 78.82 Favored Glycine 0 C--N 1.319 -0.382 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.632 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -86.54 176.43 7.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.048 0.424 . . . . 0.0 110.827 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mmt-85 -120.82 148.61 43.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 111.658 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 39' ' ' SER . 4.7 t -124.92 165.27 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.052 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 25' ' ' VAL . 2.6 p -81.68 139.57 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.0 p -54.13 101.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 0.0 110.613 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.416 ' HG2' ' HB3' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -49.03 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.588 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.7 pt-20 -95.05 134.56 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.733 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -66.21 96.98 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.957 0.408 . . . . 0.0 110.489 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.8 149.24 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.721 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -93.34 -29.05 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.127 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.67 170.3 9.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.17 -22.2 9.55 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.987 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -79.75 133.19 36.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.585 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -134.36 125.35 27.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.037 0.446 . . . . 0.0 111.621 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -106.56 150.38 26.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.796 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.14 -169.96 33.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.945 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.561 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -129.36 156.75 43.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.31 0.576 . . . . 0.0 111.588 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' A' ' 25' ' ' VAL . 77.2 t80 -139.38 145.55 39.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.918 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -59.56 86.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 110.62 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 148.04 -32.26 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.395 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -169.92 170.86 7.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 111.429 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 39' ' ' SER . 1.5 mp -119.04 158.34 20.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . 160.01 -125.53 1.49 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.196 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.644 ' O ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -98.55 146.87 25.35 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 120.504 0.193 . . . . 0.0 110.824 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -73.75 144.2 82.67 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 120.937 0.398 . . . . 0.0 111.807 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' O ' HG13 ' A' ' 52' ' ' VAL . 86.1 Cg_endo -94.64 33.99 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.262 2.642 . . . . 0.0 112.145 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -34.45 -28.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 m-20 -41.66 -28.96 0.16 Allowed 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -160.58 64.89 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 110.206 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.63 163.34 28.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.397 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 4' ' ' PHE . 8.5 tp -128.65 117.28 20.93 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.917 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -106.08 134.98 48.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.39 . . . . 0.0 111.792 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' ' CE2' ' A' ' 4' ' ' PHE . 1.7 mt-10 -103.27 115.97 31.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.75 85.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.274 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.05 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.55 0.214 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.17 -175.66 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.878 2.385 . . . . 0.0 112.572 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -97.51 171.34 8.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.192 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.9 t80 -127.38 119.22 25.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.945 0.403 . . . . 0.0 111.537 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 25' ' ' VAL . 37.2 t -73.9 135.98 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.849 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -83.3 -72.2 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.55 150.11 35.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.56 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.83 ' HB2' ' CA ' ' A' ' 21' ' ' LYS . . . -88.21 132.11 34.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.003 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.509 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 55.5 t80 -134.74 148.01 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.07 141.35 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 16' ' ' GLU . . . -138.79 -167.89 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -81.47 176.98 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.822 -179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -82.69 -154.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.084 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 15.4 mm-40 -50.29 105.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 122.127 0.965 . . . . 0.0 110.659 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 4.0 t70 152.45 -55.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.282 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' C ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -128.62 149.96 50.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.805 177.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -129.59 150.74 50.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 p -66.16 149.89 49.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.956 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 47' ' ' PHE . 2.4 mt -93.3 150.8 20.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.214 0.53 . . . . 0.0 111.309 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.844 HG11 ' HB2' ' A' ' 23' ' ' SER . 2.5 t -76.08 161.81 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.995 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.83 ' CA ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 mttt -90.18 -42.43 11.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.166 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.25 62.52 0.28 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.898 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.844 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -136.06 -170.07 2.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.625 -0.288 . . . . 0.0 110.651 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -120.43 132.26 55.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.264 0.554 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.652 HG23 HG23 ' A' ' 5' ' ' VAL . 21.4 t -110.56 166.57 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.97 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.566 HG21 ' HB2' ' A' ' 39' ' ' SER . 11.6 p -80.27 139.21 36.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.736 0.303 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.634 HG23 ' CG ' ' A' ' 54' ' ' GLU . 11.0 p -54.27 122.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.571 0.7 . . . . 0.0 111.436 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.426 ' HE1' ' H ' ' A' ' 47' ' ' PHE . 75.7 mmm -54.12 -176.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 9.0 pt-20 -111.24 140.12 46.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -69.64 96.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.53 154.12 21.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.327 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.0 t -93.36 -29.61 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.0 167.86 12.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.932 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.24 -16.3 53.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.97 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.47 96.15 7.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.298 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CE3' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -89.98 125.56 35.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.095 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.65 149.73 21.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.53 -173.19 35.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.566 ' HB2' HG21 ' A' ' 26' ' ' THR . 0.3 OUTLIER -135.11 144.27 47.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.156 0.503 . . . . 0.0 111.282 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -140.87 145.55 36.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.082 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.51 86.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.142 0.496 . . . . 0.0 110.371 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' TYR . . . 156.15 -40.77 0.58 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.066 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -169.98 162.16 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.7 mp -110.98 156.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 153.98 -137.56 5.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.617 ' O ' HD21 ' A' ' 17' ' ' LEU . 31.4 m-90 -99.26 145.42 27.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' HD22 ' A' ' 19' ' ' LEU . 1.2 t80 -141.59 119.92 7.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 19' ' ' LEU . 84.9 Cg_exo -50.6 88.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.832 2.355 . . . . 0.0 113.136 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.504 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -60.23 -12.24 8.34 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.205 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 m120 -43.75 -23.89 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.189 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -145.57 63.87 1.26 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.438 0.637 . . . . 0.0 110.571 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.504 ' CG1' ' HA ' ' A' ' 49' ' ' SER . 1.5 m -138.71 151.18 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.214 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.662 HD23 ' CD2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -106.57 117.68 34.67 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.634 ' CG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -105.31 133.92 49.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.477 . . . . 0.0 111.872 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -120.34 117.32 27.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.371 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -79.73 82.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 0.0 111.196 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.865 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.794 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.624 0.25 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.52 -165.91 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.604 2.203 . . . . 0.0 112.143 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.34 159.04 28.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.45 117.48 32.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.595 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 20' ' ' VAL . 21.2 t -87.24 148.71 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -106.0 -75.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.14 156.92 16.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.783 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . . . -105.58 147.45 28.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.551 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.425 ' N ' ' HB2' ' A' ' 19' ' ' LEU . 6.4 t80 -135.5 135.85 40.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 26.9 m -88.89 108.23 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.266 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 162.14 88.39 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 116.59 20.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.137 0.494 . . . . 0.0 111.137 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.17 149.46 22.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.354 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 pt-20 -54.16 106.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 36.2 t70 124.69 -31.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.932 0.77 . . . . 0.0 110.364 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 9.5 pt-20 -108.34 149.94 28.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.614 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.927 HD23 ' CE3' ' A' ' 46' ' ' TRP . 3.2 pp -107.56 131.94 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.703 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 54.4 p -106.7 146.96 30.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.535 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 50' ' ' ASN . 3.0 mm? -95.38 149.68 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.309 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' H ' HG11 ' A' ' 5' ' ' VAL . 2.0 t -94.85 164.68 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.215 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.783 ' HA ' ' HB2' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -73.3 -52.12 15.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.31 27.35 0.12 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.779 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.408 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -95.74 171.38 8.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -101.31 148.71 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 40' ' ' TYR . 25.9 t -124.94 165.26 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.102 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.533 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.4 p -81.24 139.01 35.73 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.4 p -54.84 118.48 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.369 0.604 . . . . 0.0 111.216 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.471 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -60.55 -175.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.17 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -95.51 161.88 13.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.138 -179.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -126.35 99.47 5.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.861 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.26 157.97 17.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -59.89 -26.39 65.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.932 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.84 169.15 14.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.931 0.396 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 36' ' ' TRP . . . -74.18 -7.63 77.54 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.255 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -86.49 133.16 33.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.992 0.396 . . . . 0.0 110.925 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 10.6 m-90 -141.12 126.13 18.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.37 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.4 149.05 24.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.076 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -134.07 158.43 23.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.852 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -111.07 153.35 25.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CE2' HG22 ' A' ' 25' ' ' VAL . 8.1 m-85 -122.8 145.03 48.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.94 86.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.21 -15.32 7.3 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.568 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.764 ' C ' HD12 ' A' ' 44' ' ' ILE . 7.0 pt20 -159.25 174.83 14.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.292 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.764 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -136.96 156.83 35.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.94 0.4 . . . . 0.0 111.467 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . -176.05 -146.18 5.85 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CE3' HD23 ' A' ' 17' ' ' LEU . 2.1 t90 -99.3 146.36 26.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.961 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.901 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -55.73 113.24 5.32 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 17' ' ' LEU . 74.0 Cg_endo -94.49 37.04 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.091 2.527 . . . . 0.0 111.637 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.587 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -53.55 -9.6 0.21 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 19' ' ' LEU . 3.3 m-20 -42.35 -30.43 0.33 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 91.3 m-85 -157.81 64.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.209 0.528 . . . . 0.0 109.745 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -139.01 163.46 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.476 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 18.2 tp -114.46 116.92 29.63 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.705 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.62 ' OE1' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -106.54 137.03 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.912 0.387 . . . . 0.0 112.009 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.794 ' O ' HD13 ' A' ' 1' ' ' ILE . 0.6 OUTLIER -117.26 115.83 26.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG23 ' OE1' ' A' ' 54' ' ' GLU . 56.6 t -96.43 80.93 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.181 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.88 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.557 0.218 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.95 -170.75 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -98.0 170.93 8.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 53' ' ' LEU . 76.2 t80 -131.35 130.05 42.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.912 0.387 . . . . 0.0 111.729 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 19' ' ' LEU . 35.1 t -85.12 135.74 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -86.79 -47.85 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.504 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.01 150.63 44.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.326 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -82.33 139.88 33.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . 6.6 t80 -135.67 125.09 24.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.1 m -88.79 108.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.776 ' HB1' ' OE2' ' A' ' 16' ' ' GLU . . . -178.57 104.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.3 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.49 117.58 22.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.289 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.737 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -155.3 175.24 14.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.392 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.737 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 19.3 pt-20 -53.62 108.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.384 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER 87.13 10.96 0.14 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.776 ' OE2' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -127.25 137.75 52.94 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.998 0.428 . . . . 0.0 110.721 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.73 143.42 50.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 p -76.86 147.33 37.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD21 ' CB ' ' A' ' 48' ' ' PRO . 3.8 mm? -95.24 150.5 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.127 0.489 . . . . 0.0 111.61 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 23' ' ' SER . 0.9 OUTLIER -91.73 152.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.732 ' HE2' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.22 -42.4 95.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.87 24.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.267 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.782 ' HB2' HG11 ' A' ' 20' ' ' VAL . 13.8 t -78.12 -171.63 2.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.101 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -118.85 148.65 42.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.058 0.456 . . . . 0.0 111.235 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG13 ' CG ' ' A' ' 40' ' ' TYR . 42.6 t -121.44 165.52 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.586 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.561 ' N ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -80.93 139.95 35.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.7 p -53.68 90.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 110.55 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 26' ' ' THR . 1.6 mpp? -57.8 -175.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.688 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HB2' ' CD1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -95.93 161.19 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.011 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -135.29 96.69 3.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.947 0.403 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' CE2' ' A' ' 36' ' ' TRP . 25.0 t -107.14 157.68 17.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.178 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -56.57 -43.96 80.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.8 167.87 20.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.45 -21.02 63.01 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.966 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -82.12 104.59 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.595 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -160.98 133.94 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 3.9 mtt180 -111.34 130.04 55.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CG ' ' A' ' 28' ' ' MET . . . -102.73 -160.61 25.79 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.555 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.509 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -134.63 152.74 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.455 0.645 . . . . 0.0 111.947 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.689 ' CE1' HD22 ' A' ' 17' ' ' LEU . 14.3 m-85 -132.0 144.84 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.813 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -60.9 86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.69 -20.36 4.36 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.711 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.8 pt20 -169.68 165.86 9.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.246 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -117.54 159.41 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.074 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.449 ' HA2' ' NE ' ' A' ' 37' ' ' ARG . . . -175.47 -151.67 8.81 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.385 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.66 ' O ' HD21 ' A' ' 17' ' ' LEU . 69.0 t90 -97.36 130.08 44.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.2 114.29 10.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.698 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.907 ' CB ' HD21 ' A' ' 19' ' ' LEU . 81.6 Cg_endo -90.16 49.1 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.999 2.466 . . . . 0.0 111.711 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.544 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -37.05 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.9 m120 -42.37 -28.31 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.727 0.299 . . . . 0.0 111.418 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 61.4 m-85 -156.75 64.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.161 0.505 . . . . 0.0 109.944 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -138.91 163.32 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.648 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -126.53 116.78 21.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 56' ' ' VAL . 1.5 tt0 -106.45 127.06 53.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.871 0.367 . . . . 0.0 111.712 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.64 116.01 30.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.504 HG22 ' OE2' ' A' ' 54' ' ' GLU . 21.4 t -80.17 80.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.843 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.542 0.211 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.35 -167.43 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.715 2.277 . . . . 0.0 112.287 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -120.42 157.79 28.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 6.3 m-85 -109.81 116.29 31.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 20' ' ' VAL . 38.6 t -84.46 152.16 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.692 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 14.2 mtpt -111.53 -48.77 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 157.07 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.63 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.23 143.96 29.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.625 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 t80 -135.72 135.88 40.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.0 m -88.66 108.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.306 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.82 107.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.39 117.15 21.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.275 0.56 . . . . 0.0 111.151 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.35 159.74 39.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.151 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.643 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 9.9 pt-20 -54.06 106.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.9 t0 97.47 0.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.961 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -127.35 129.46 47.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.7 pt? -127.51 142.7 51.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.064 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -72.21 147.16 46.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.944 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.625 HD12 ' HB2' ' A' ' 9' ' ' TYR . 5.0 mt -95.29 151.02 19.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.228 0.537 . . . . 0.0 111.688 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.72 165.2 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.188 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -109.7 105.15 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.775 0.797 . . . . 0.0 111.295 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.57 18.58 73.9 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.375 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -97.91 -178.45 4.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.731 0.3 . . . . 0.0 110.951 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' CZ ' ' CZ ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -120.37 148.4 43.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.15 0.5 . . . . 0.0 111.25 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 40' ' ' TYR . 4.0 t -120.83 166.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.832 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 39' ' ' SER . 5.5 p -80.27 139.49 36.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.9 p -54.14 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.802 0.81 . . . . 0.0 111.651 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.493 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -51.93 -175.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.851 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.94 152.39 18.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.271 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.79 96.5 10.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.694 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 36' ' ' TRP . 13.0 t -99.42 143.16 29.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.827 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 -44.79 8.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.527 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -146.58 106.16 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.686 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.45 -134.55 5.22 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.841 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -104.53 133.95 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.817 0.341 . . . . 0.0 110.609 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -88.61 125.25 34.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 111.204 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' MET . 0.0 OUTLIER -93.66 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.69 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -168.83 167.63 40.54 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.071 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.623 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.8 m -125.33 156.38 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 111.448 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.548 ' HB2' HG13 ' A' ' 25' ' ' VAL . 24.1 t80 -149.07 144.94 27.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.227 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.06 86.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.81 -27.43 1.46 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.395 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 44' ' ' ILE . 6.9 pt20 -169.74 167.52 9.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 111.58 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' GLY . 1.1 mp -136.14 156.74 37.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.939 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 147.38 -100.39 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.561 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -99.21 146.29 26.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.48 148.67 74.03 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 52' ' ' VAL . 89.7 Cg_endo -93.12 32.21 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.062 2.508 . . . . 0.0 111.888 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -39.33 -21.63 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.511 ' CB ' HD11 ' A' ' 19' ' ' LEU . 1.7 m120 -41.31 -31.07 0.2 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 63.8 m-85 -160.69 64.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.864 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -138.77 163.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.223 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -124.2 117.84 25.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.734 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.4 129.87 53.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 0.0 111.768 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.53 138.17 32.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.748 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.88 75.81 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.267 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.878 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.537 0.208 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 92.8 Cg_endo -86.05 -167.13 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.602 2.201 . . . . 0.0 112.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . -112.7 155.39 24.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 m-85 -109.2 116.38 31.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.673 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 23' ' ' SER . 59.9 t -77.63 158.62 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.687 0.28 . . . . 0.0 110.752 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 5' ' ' VAL . 13.4 mtpt -114.54 -69.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.806 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.2 157.05 25.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.75 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' HB2' ' N ' ' A' ' 21' ' ' LYS . . . -96.98 138.87 33.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.201 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.414 ' CB ' ' HB2' ' A' ' 19' ' ' LEU . 3.1 t80 -136.0 131.68 35.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 10' ' ' VAL . 3.2 m -88.72 108.54 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 95.49 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.16 117.02 28.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.282 0.563 . . . . 0.0 110.921 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -156.17 156.65 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.173 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 6.8 pt-20 -54.04 106.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.7 t70 105.15 -17.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.922 0.764 . . . . 0.0 110.963 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -114.14 141.33 47.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.966 HD21 ' O ' ' A' ' 46' ' ' TRP . 0.3 OUTLIER -129.44 149.36 51.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.03 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 p -77.68 148.11 35.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 48' ' ' PRO . 3.5 mm? -94.42 148.96 21.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.04 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 23' ' ' SER . 1.9 t -95.81 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.323 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -67.23 -36.12 81.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.189 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.02 32.09 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.265 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -79.09 -176.93 5.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.322 . . . . 0.0 110.894 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' NE ' ' CZ ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -120.45 148.73 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' CD2' ' A' ' 40' ' ' TYR . 40.6 t -119.89 165.85 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.687 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.83 HG23 ' HA ' ' A' ' 40' ' ' TYR . 1.6 p -80.41 140.79 35.84 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 27' ' ' VAL . 8.3 p -52.68 97.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 122.06 0.933 . . . . 0.0 110.312 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -48.72 -176.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 113.768 -1.56 . . . . 0.0 112.744 -178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CD1' ' A' ' 36' ' ' TRP . 2.6 pt-20 -96.0 161.96 13.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.754 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -78.19 144.28 36.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -104.53 145.72 29.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.787 0.327 . . . . 0.0 110.781 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -93.47 -45.42 7.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -147.42 97.38 2.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.852 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.34 -41.68 0.13 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.302 0.881 . . . . 0.0 115.302 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' O ' ' CG ' ' A' ' 35' ' ' TRP . 4.4 p-90 -79.31 113.13 17.2 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.983 0.892 . . . . 0.0 112.08 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.548 ' HB3' ' CG ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -116.97 126.18 52.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.661 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' MET . 0.0 OUTLIER -104.74 150.03 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 28' ' ' MET . . . -149.39 171.82 29.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.107 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.634 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 42.6 m -131.77 156.92 45.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.394 0.616 . . . . 0.0 112.276 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.83 ' HA ' HG23 ' A' ' 26' ' ' THR . 1.2 m-85 -136.68 144.84 44.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -61.46 86.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.889 0.376 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.18 -13.77 5.97 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.138 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.733 ' C ' HD12 ' A' ' 44' ' ' ILE . 5.4 pt20 -168.88 152.4 5.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.072 0.436 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.7 mp -125.19 158.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 177.01 -144.47 6.81 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.618 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.966 ' O ' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -98.76 138.1 36.4 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 110.773 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -54.29 138.5 58.0 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HB2' HD11 ' A' ' 19' ' ' LEU . 60.9 Cg_endo -99.86 28.96 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.976 3.118 . . . . 0.0 111.821 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -30.9 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 2.5 m120 -41.4 -32.43 0.32 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CG ' ' O ' ' A' ' 50' ' ' ASN . 69.0 m-85 -158.31 64.62 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 0.0 110.018 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.77 HG22 ' HA ' ' A' ' 49' ' ' SER . 1.0 OUTLIER -139.05 163.54 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 10.8 tp -129.23 117.19 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.958 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.1 131.47 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.715 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 2' ' ' PRO . 1.4 mt-10 -102.25 121.13 41.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.373 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 t -79.62 83.7 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.113 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.954 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.666 HD13 ' O ' ' A' ' 55' ' ' GLU . 1.2 pp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.519 0.199 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.35 -166.77 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.682 2.255 . . . . 0.0 112.264 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' LEU . . . -122.29 163.87 18.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.122 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -113.68 116.13 28.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.716 0.293 . . . . 0.0 111.086 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.681 HG11 ' H ' ' A' ' 20' ' ' VAL . 14.9 t -87.68 145.38 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.7 -81.46 0.54 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.858 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.74 154.68 19.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.864 0.364 . . . . 0.0 111.427 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.683 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -115.11 145.55 42.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.862 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 5.3 t80 -135.6 139.45 43.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.494 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 7.6 m -88.75 108.48 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 169.26 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.244 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -127.74 116.73 20.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 110.511 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -157.05 153.44 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.862 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.51 106.32 0.28 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 11.8 t70 118.45 -28.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.481 0.712 . . . . 0.0 110.624 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 13' ' ' ARG . 12.8 pt-20 -106.04 150.04 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.207 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -127.01 121.03 30.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 11.3 p -80.41 147.07 31.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.769 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -95.56 151.13 19.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 0.0 111.479 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.683 ' C ' ' HB2' ' A' ' 8' ' ' ALA . 2.3 t -91.52 164.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.704 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.2 -39.01 41.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.422 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.79 33.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.81 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.632 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -102.59 165.87 10.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.804 0.335 . . . . 0.0 110.804 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.12 148.61 23.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 40' ' ' TYR . 3.9 t -120.21 164.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.254 0.549 . . . . 0.0 112.072 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 25' ' ' VAL . 3.4 p -81.68 140.73 34.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.6 p -53.45 91.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 122.094 0.95 . . . . 0.0 110.577 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.531 ' CB ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -47.3 -175.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.659 -1.61 . . . . 0.0 113.458 -178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 11.5 pt-20 -95.75 161.3 14.08 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.088 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -109.05 96.15 6.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 p -97.41 158.13 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.128 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -90.44 -6.33 55.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.404 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -104.26 175.45 5.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.011 0.434 . . . . 0.0 111.044 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.0 74.28 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.713 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 35' ' ' TRP . 42.6 p-90 -79.99 98.94 7.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.364 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -89.96 125.07 35.24 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -96.25 150.19 20.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 28' ' ' MET . . . -165.88 -176.46 37.25 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.94 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -134.94 142.5 46.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.845 0.322 . . . . 0.0 111.06 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -137.37 144.4 42.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 111.093 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.55 90.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.45 -27.46 2.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.093 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.705 ' C ' HD12 ' A' ' 44' ' ' ILE . 1.1 pt20 -169.72 154.51 5.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 ' C ' ' A' ' 43' ' ' GLN . 1.6 mp -120.83 158.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.463 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 44' ' ' ILE . . . 155.13 -128.3 2.27 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 17' ' ' LEU . 25.5 m-90 -99.02 140.44 33.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.538 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.842 ' O ' HD22 ' A' ' 17' ' ' LEU . 49.5 p90 -91.77 141.9 26.08 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.802 ' HA ' HD13 ' A' ' 17' ' ' LEU . 41.6 Cg_endo -92.0 58.83 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.512 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.429 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -49.81 -19.57 0.68 Allowed 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -42.86 -27.88 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.663 0.268 . . . . 0.0 111.662 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -154.42 64.98 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 109.92 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -138.09 163.36 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -113.43 116.97 30.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.39 136.17 46.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 1' ' ' ILE . 1.6 mt-10 -118.12 116.0 25.96 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.22 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.91 74.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 111.324 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.836 179.993 . . . . . . . . 0 0 . 1 stop_ save_